<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Clin Shoulder Elb</journal-id><journal-id journal-id-type="iso-abbrev">Clin Shoulder Elb</journal-id><journal-id journal-id-type="pmc-domain-id">3958</journal-id><journal-id journal-id-type="pmc-domain">cise</journal-id><journal-id journal-id-type="publisher-id">CISE</journal-id><journal-title-group><journal-title>Clinics in Shoulder and Elbow</journal-title></journal-title-group><issn pub-type="ppub">2383-8337</issn><issn pub-type="epub">2288-8721</issn><publisher><publisher-name>Korean Shoulder and Elbow Society</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12151653</article-id><article-id pub-id-type="pmcid-ver">PMC12151653.1</article-id><article-id pub-id-type="pmcaid">12151653</article-id><article-id pub-id-type="pmcaiid">12151653</article-id><article-id pub-id-type="pmid">40275805</article-id><article-id pub-id-type="doi">10.5397/cise.2024.00906</article-id><article-id pub-id-type="publisher-id">cise-2024-00906</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Early complications and risk factors following reverse versus anatomic total shoulder arthroplasty for osteoarthritis: a nationwide registry study</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-3270-338X</contrib-id><name name-style="western"><surname>Velichala</surname><given-names initials="SR">Suhas Rao</given-names></name><xref rid="c1-cise-2024-00906" ref-type="corresp"/><xref rid="af1-cise-2024-00906" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0009-0001-4573-6914</contrib-id><name name-style="western"><surname>Lieu</surname><given-names initials="BA">Brigitte A.</given-names></name><xref rid="af1-cise-2024-00906" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0009-0006-0416-3060</contrib-id><name name-style="western"><surname>Sharma</surname><given-names initials="A">Aadi</given-names></name><xref rid="af1-cise-2024-00906" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0009-0005-5055-8672</contrib-id><name name-style="western"><surname>Smith</surname><given-names initials="M">Matthew</given-names></name><xref rid="af2-cise-2024-00906" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-3953-0917</contrib-id><name name-style="western"><surname>Satalich</surname><given-names initials="J">James</given-names></name><xref rid="af2-cise-2024-00906" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-4322-2063</contrib-id><name name-style="western"><surname>Vanderbeck</surname><given-names initials="J">Jennifer</given-names></name><xref rid="af2-cise-2024-00906" ref-type="aff">
<sup>2</sup>
</xref></contrib><aff id="af1-cise-2024-00906">
<label>1</label>Virginia Commonwealth University School of Medicine, Richmond, VA, <country>USA</country></aff><aff id="af2-cise-2024-00906">
<label>2</label>Department of Orthopaedic Surgery, Virginia Commonwealth University Health System, Richmond, VA, <country>USA</country></aff></contrib-group><author-notes><corresp id="c1-cise-2024-00906">Corresponding Author: Suhas Rao Velichala Virginia Commonwealth University School of Medicine, 1201 E Marshall St #4-100, Richmond, VA 23298, USA Tel: +1-626-340-5517 1 3Email: <email>velichalasr@vcu.edu</email></corresp></author-notes><pub-date pub-type="collection"><month>6</month><year>2025</year></pub-date><pub-date pub-type="epub"><day>25</day><month>4</month><year>2025</year></pub-date><volume>28</volume><issue>2</issue><issue-id pub-id-type="pmc-issue-id">490333</issue-id><fpage>146</fpage><lpage>155</lpage><history><date date-type="received"><day>5</day><month>11</month><year>2024</year></date><date date-type="rev-recd"><day>8</day><month>1</month><year>2025</year></date><date date-type="accepted"><day>24</day><month>1</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>25</day><month>04</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>11</day><month>06</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-06-11 16:25:55.977"><day>11</day><month>06</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>&#169; 2025 Korean Shoulder and Elbow Society</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbynclicense">https://creativecommons.org/licenses/by-nc/4.0/</ali:license_ref><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc/4.0/">http://creativecommons.org/licenses/by-nc/4.0/</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="cise-2024-00906.pdf"/><abstract><sec><title>Background</title><p>Reverse shoulder arthroplasty (RSA) is an alternative to anatomic total shoulder arthroplasty (TSA) for treating glenohumeral osteoarthritis (OA), particularly in elderly patients. This study evaluates 90-day postoperative complication rates and identifies risk factors for adverse outcomes in RSA and TSA patients.</p></sec><sec><title>Methods</title><p>A retrospective cohort study was conducted using the TriNetX Research NLP Network to identify patients aged 65&#8211;90 years who underwent RSA or TSA for OA from 2006 to 2024. 1:1 propensity score matching controlled for demographics and comorbidities. Orthopedic and infectious complications were compared using multivariate logistic regression.</p></sec><sec><title>Results</title><p>The final matched cohort included 4,117 RSA and TSA patients. RSA was associated with significantly higher odds of orthopedic complications compared to TSA. Significant risk factors for orthopedic complications in RSA included nicotine dependence (odds ratio [OR], 1.592; P=0.001) and hypertension (OR, 1.545; P=0.001). In TSA, risk factors included male sex (OR, 0.702; P=0.005), chronic obstructive pulmonary disease (OR, 1.650; P=0.016), and obesity (OR, 1.776; P&lt;0.001). For infections, RSA risk factors were male sex (OR, 1.698; P=0.005), heart failure (OR, 2.396; P&lt;0.001), and diabetes (OR, 1.525; P=0.039). Diabetes was the only significant risk factor in TSA (OR, 2.453; P=0.003).</p></sec><sec><title>Conclusions</title><p>RSA carries a higher risk of orthopedic complications and infection than TSA within 90 days. Distinct risk factors for each procedure highlight the need for patient-specific risk stratification to optimize preoperative assessment and surgical decision-making.</p></sec><sec><title>Level of evidence</title><p>III.</p></sec></abstract><kwd-group><kwd>Reverse</kwd><kwd>Total</kwd><kwd>Shoulder</kwd><kwd>Arthroplasty</kwd><kwd>Osteoarthritis</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro"><title>INTRODUCTION</title><p>Anatomic total shoulder arthroplasty (TSA) has been the standard of care for the surgical treatment of end-stage glenohumeral osteoarthritis (OA), a condition estimated to affect 16.1%&#8211;20.1% of individuals older than 65 years [<xref rid="b1-cise-2024-00906" ref-type="bibr">1</xref>-<xref rid="b3-cise-2024-00906" ref-type="bibr">3</xref>]. Reverse shoulder arthroplasty (RSA) is an alternative to TSA that has gained popularity in recent years for the treatment of glenohumeral OA, largely due to a lower dependency on rotator cuff condition and the potential for faster rehabilitation of functions such as forward elevation strength [<xref rid="b1-cise-2024-00906" ref-type="bibr">1</xref>,<xref rid="b4-cise-2024-00906" ref-type="bibr">4</xref>-<xref rid="b8-cise-2024-00906" ref-type="bibr">8</xref>]. As glenohumeral OA becomes more prevalent in an aging population, it is important to understand the potential complications associated with each shoulder arthroplasty approach and corresponding risk factors observed in the elderly population [<xref rid="b9-cise-2024-00906" ref-type="bibr">9</xref>]. Prior studies have described higher all-cause postoperative complication rate for RSA compared to anatomic TSA with infection, dislocation, and revision surgery occurring at a significantly higher rate following RSA when compared to TSA [<xref rid="b10-cise-2024-00906" ref-type="bibr">10</xref>,<xref rid="b11-cise-2024-00906" ref-type="bibr">11</xref>]. However, recent investigations have provided evidence of the contrary, with one meta-analysis describing an advantage of RSA with respect to the rate of reoperation, complications, and several functional outcomes for patients receiving treatment for OA with an intact cuff [<xref rid="b12-cise-2024-00906" ref-type="bibr">12</xref>]. More research is needed to establish a consensus regarding the risk profile for RSA versus TSA when applied to more recently emerged indications such as OA.</p><p>Much of the existing literature assessed the outcomes of shoulder arthroplasty performed for a broad range of indications, while little research has compared outcomes of RSA and TSA performed electively for OA specifically [<xref rid="b13-cise-2024-00906" ref-type="bibr">13</xref>]. The present study aims to more comprehensively compare the rate of orthopedic complications in the 90-day period following TSA versus RSA among patients with OA affecting the shoulder, and to investigate risk factors for these complications. Whereas previous studies compared outcomes for RSA versus TSA, to the best of our knowledge, none have performed a highly powered database study examining such a broad array of surgical complications and their associated risk factors. We hypothesized that RSA carries a significantly higher risk of orthopedic and infectious complications compared with TSA in the 90-day postoperative period for elderly patients with glenohumeral OA, with certain comorbidities such as diabetes, hypertension, depression, and liver disease further exacerbating these risks.</p></sec><sec sec-type="methods"><title>METHODS</title><sec><title>TriNetX Database</title><p>This retrospective cohort study used de-identified electronic health record (EHR) data from the TriNetX Research Network, which aggregates data from 92 healthcare organizations (HCOs), including hospitals, primary care, and specialty providers across diverse patient populations. The study specifically queried TriNetX&#8217;s Natural Language Processing dataset, which includes both insured and uninsured patients.</p><p>TriNetX has been reviewed by the Western Institutional Review Board, and since only de-identified data were used, additional IRB approval and informed consent was not required. TriNetX offers access to continuously updated, de-identified aggregate EHR data, including demographics, diagnoses, procedures, medications, laboratory values, genomics, and cohort analysis tools. Detailed information regarding the TriNetX database and software has been previously published [<xref rid="b14-cise-2024-00906" ref-type="bibr">14</xref>,<xref rid="b15-cise-2024-00906" ref-type="bibr">15</xref>].</p></sec><sec><title>Cohorts</title><p>Patients aged 65 and older undergoing TSA or RSA on or prior to September 23, 2024, with a previous diagnosis of shoulder OA were first queried. All patients with diagnoses of rotator cuff pathologies prior to their procedure were excluded using the following codes: M75.1A, M75.5A, and S46.0A. The diagnosis of OA in both cohorts was identified using the following International Classification of Diseases, 10th Revision, Clinical Modification (ICD-10-CM) codes: M19.019, M19.012, M19.011, M19.21, M12.211, M19.212, and M19.219. RSA patients were identified with the ICD-10 Procedure Coding System (ICD-10-PCS) codes 0RRK00Z and 0RRJ00Z, whereas TSA patients were identified with the ICD-10-PCS codes 0RRJ0JZ, 0RRJ07Z, 0RRK0JZ, 0RRK07Z, 0RRJ0KZ, and 0RRK0KZ. Each cohort excluded patients identified by the ICD-10-PCS codes of the other cohort.</p></sec><sec><title>Analysis and Statistics</title><p>Demographic and patient characteristic data were collected and compared using TriNetX&#8217;s cohort comparison tools. Propensity score matching was conducted using the platform, which applies logistic regression to user-defined covariates to generate propensity scores for individual subjects. A 1:1 matching approach was then performed using a greedy nearest neighbor algorithm with a caliper width of 0.1 pooled standard deviations. To mitigate bias associated with the nearest neighbor algorithm, TriNetX randomizes the row order during the matching process. The matched characteristics and comorbidities included average age at index, sex, race, body mass index (BMI), and the incidence of hypertension, diabetes, nicotine dependence, heart failure, chronic obstructive pulmonary disease (COPD), end-stage renal disease (ESRD), and ascites. Standardized mean differences (SMDs) were used to ascertain the distribution balance among our baseline variables. All variables had SMD values of less than 0.1 and were considered well-matched.</p><p>Following matching, infectious and orthopedic complication rates were tracked in each cohort from the first day after surgery (index event) for 90 days. Pertinent codes used to query these outcomes are found in <xref rid="SD1-cise-2024-00906" ref-type="supplementary-material">Supplementary Table 1</xref>. An additional category named &#8220;Any Orthopedic Complication&#8221; was created to ascertain an overview of musculoskeletal adverse events including dislocation, periprosthetic fracture, scapula fracture, implant loosening, stiffness, rotator cuff injury, and hematoma. Risk differences were utilized to compare outcomes across groups, and significant differences were calculated with t-tests using the TriNetX platform. Significance was set at P&lt;0.05.</p><p>Additionally, multivariable risk factor analysis was conducted independently for both the RSA and TSA cohorts using TriNetX&#8217;s logistic regression tool. This analysis examined the risk for orthopedic and infectious complications concerning patient comorbidities. Infections as an outcome of logistic regression were defined by the presence of any of the following: musculoskeletal infection, deep and superficial surgical site infection, wound dehiscence, unspecified infection, or sepsis (<xref rid="SD1-cise-2024-00906" ref-type="supplementary-material">Supplementary Table 1</xref>). P-values less than 0.05 were considered significant.</p></sec></sec><sec sec-type="results"><title>RESULTS</title><p>This study included 5,058 patients who underwent RSA and 6,064 patients who underwent TSA. After 1:1 propensity matching, 4,117 patients were extracted from the cohorts (<xref rid="f1-cise-2024-00906" ref-type="fig">Fig. 1</xref>). The average age was similar between the RSA (72.67&#177;5.00 years) and TSA (72.6&#177;4.77 years) groups (P=0.291). Sex distribution showed no significant differences, with 55.55% females in the RSA group and 55.14% in the TSA group (P=0.706), and racial and ethnicity distributions remained comparable, with no significant differences. Comorbidities such as hypertension, diabetes mellitus, nicotine dependence, heart failure, COPD, ESRD, and ascites were also similar between the matched RSA and TSA cohorts. Statistically significant differences in BMI (30.7&#177;6.60 in RSA vs. 30.2&#177;6.11 in TSA) persisted despite matching (<xref rid="t1-cise-2024-00906" ref-type="table">Table 1</xref>).</p><p>In the matched cohorts, significant differences were observed in postoperative complications between RSA and TSA patients (<xref rid="t2-cise-2024-00906" ref-type="table">Table 2</xref>). The RSA group had a significantly higher musculoskeletal infection rate than the TSA group (1.39% vs. 0.39%, P&lt;0.001). Additionally, &#8220;any orthopedic complication&#8221; was more common in the RSA group, occurring in 7.65% of patients compared to 6.63% in the TSA group, though this difference did not reach statistical significance (P=0.072).</p><p>Specific orthopedic complications were significantly more frequent in the RSA group. Dislocations were notably higher among RSA patients, occurring in 0.87% of cases compared to 0.27% in the TSA group (P&lt;0.001). Periprosthetic fractures were also significantly more common following RSA (0.85% vs. 0.24%, P&lt;0.001). Stiffness occurred at a higher rate in TSA patients (5.51%) compared to RSA patients (4.23%), showing a statistically significant difference (P=0.006). Rotator cuff injuries were more prevalent in the RSA group (1.43%) compared to the TSA group (0.41%) with a risk difference of 1.02% (P&lt;0.001).</p><p>Beyond orthopedic complications, the RSA group demonstrated significantly higher rates of renal complications (4.20% vs. 2.84%, P&lt;0.001), cardiovascular complications (6.32% vs. 5.27%, P=0.043), urinary tract infections (UTIs; 1.84% vs. 1.29%, P=0.041), and deep vein thrombosis (0.56% vs. 0.95%, P=0.041). Other vascular complications were significantly less common in RSA compared to TSA (0.56% vs. 1.00%, P=0.024). No significant differences were observed between groups in terms of surgical site infection, gastrointestinal complications, and hematological complications.</p><p><xref rid="t3-cise-2024-00906" ref-type="table">Table 3</xref> presents multivariate risk factor analysis for orthopedic complications based on comorbidities of patients undergoing RSA or TSA for OA. In the RSA group, significant risk factors for orthopedic complications included a personal history of nicotine dependence (odds ratio [OR], 1.592; 95% CI, 1.204&#8211;2.106; P=0.001) and hypertension (OR, 1.545; 95% CI, 1.196&#8211;1.997; P=0.001). Age at index was identified as a protective factor, with an OR of 0.962 (95% CI, 0.942&#8211;0.983; P&lt;0.001), suggesting that increasing age was associated with a reduced likelihood of orthopedic complications following RSA.</p><p>In the TSA group, significant risk factors for orthopedic complications included male sex (OR, 0.702; 95% CI, 0.550&#8211;0.906; P=0.005), COPD (OR, 1.650; 95% CI, 1.099&#8211;2.478; P=0.016), overweight/obesity (OR, 1.776; 95% CI, 1.318&#8211;2.393; P&lt;0.001), and hypertension (OR, 1.769; 95% CI, 1.348&#8211;2.323; P&lt;0.001). Age at index was also a significant protective factor in TSA, with an OR of 0.962 (95% CI, 0.937&#8211;0.988; P=0.004), consistent with the trend observed in RSA patients.</p><p><xref rid="t4-cise-2024-00906" ref-type="table">Table 4</xref> presents the multivariate risk factor analysis for infection based on comorbidities of patients undergoing RSA or TSA for OA. In the RSA group, significant risk factors for infection included heart failure (OR, 2.396; 95% CI, 1.504&#8211;3.818; P&lt;0.001), male sex (OR, 1.698; 95% CI, 1.175&#8211;2.452; P=0.005), and diabetes mellitus (OR, 1.525; 95% CI, 1.022&#8211;2.277; P=0.039). Age at index was protective against infection, with an OR of 0.939 (95% CI, 0.905&#8211;0.974; P=0.001), indicating that increasing age was associated with a decreased likelihood of infection following RSA. In the TSA group, diabetes mellitus was a significant risk factor for infection (OR, 2.453; 95% CI, 1.362&#8211;4.416; P=0.003). No other comorbidities were significantly associated with infection in the TSA cohort.</p></sec><sec sec-type="discussion"><title>DISCUSSION</title><p>This study compared 90-day orthopedic and infectious complications following TSA vs. RSA for OA, identifying associated risk factors. While prior research examined shoulder arthroplasty complications, few studies focus specifically on TSA vs. RSA in OA and sought to identify relevant risk factors for adverse events. To the best of our knowledge, this is the largest database study on this topic conducted to inform surgical decision-making by identifying high-risk patient populations.</p><sec><title>Postoperative Complications</title><p>Patients treated with RSA experienced a significantly higher number of musculoskeletal infections compared to TSA. In contrast to Ross et al. [<xref rid="b16-cise-2024-00906" ref-type="bibr">16</xref>], who reported a 0.5% rate of prosthetic joint infections 90 days following RSA, our rate of musculoskeletal infections was two-fold that rate at 1.39%. Variation in diagnosis codes across studies when defining infection may yield differences in results, as our musculoskeletal infection category consisted of multiple diagnosis codes. Nonetheless, our findings are compatible with prior literature, which generally reported higher rates of infectious complications following RSA compared to TSA [<xref rid="b16-cise-2024-00906" ref-type="bibr">16</xref>,<xref rid="b17-cise-2024-00906" ref-type="bibr">17</xref>]. Previously suggested mechanisms to explain this disparity ranged from variation in implant type to surgical techniques [<xref rid="b18-cise-2024-00906" ref-type="bibr">18</xref>]. Overall, the rate of musculoskeletal infections following shoulder arthroplasty in our study fell within the published range of 1% to 10% of prosthetic joint infections [<xref rid="b19-cise-2024-00906" ref-type="bibr">19</xref>].</p><p>Although RSA may be performed in patients with existing rotator cuff deficiencies, patients with a previous diagnosis of rotator cuff arthropathy were excluded from this study to identify new postoperative deficiencies. A significantly lower number of postoperative rotator cuff injuries were found in patients treated with TSA than RSA. The higher rate of rotator cuff injuries following RSA in our study may reflect intraoperative variation between RSA and TSA, with undiagnosed rotator cuff deficiencies more frequently discovered during RSA. This warrants further investigation [<xref rid="b20-cise-2024-00906" ref-type="bibr">20</xref>].</p><p>Postoperative dislocation was observed at a higher rate following RSA, at 0.87% compared to0.27% in TSA in the present study. Rates of dislocation in RSA vary widely from 2.4% to 31% in the existing literature, whereas our study found a dislocation rate under 1% [<xref rid="b21-cise-2024-00906" ref-type="bibr">21</xref>]. We hypothesize that an outcome window of 90 days may have been insufficient to capture the true rate, accounting for this difference. Instability in RSA may vary from TSA due to differences related to implant type, lack of soft tissue tension, impingement, and a deltopectoral approach leading to eventual dislocation [<xref rid="b19-cise-2024-00906" ref-type="bibr">19</xref>,<xref rid="b22-cise-2024-00906" ref-type="bibr">22</xref>]. Furthermore, RSA places greater reliance on the deltoid muscle, and inadequate tension may create instability or future dislocations. Finally, greater BMI, as seen with the RSA cohort, as well as a history of prior surgery (not accounted for in this study) constitute potential nonsurgical risk factors for dislocation [<xref rid="b18-cise-2024-00906" ref-type="bibr">18</xref>].</p><p>Stiffness was observed at greater rates in our TSA cohort (5.51%) compared to RSA (4.23%). Although few studies have examined this relationship in the context of OA, the higher rate of early stiffness following TSA compared to RSA is logical considering their respective postoperative rehabilitation protocols. TSA involves relatively stricter postoperative immobilization, whereas early range of motion is more strongly encouraged in RSA [<xref rid="b23-cise-2024-00906" ref-type="bibr">23</xref>,<xref rid="b24-cise-2024-00906" ref-type="bibr">24</xref>]. Although early stiffness during the 90-day postoperative period is not necessarily indicative of a surgical complication, it can persist beyond 1-year postoperative in up to 25% of patients following RSA, limiting shoulder function, decreasing patient satisfaction, and necessitating reoperation [<xref rid="b17-cise-2024-00906" ref-type="bibr">17</xref>,<xref rid="b25-cise-2024-00906" ref-type="bibr">25</xref>]. Still, despite increased stiffness, TSA generally yields better postoperative range of motion compared to RSA [<xref rid="b26-cise-2024-00906" ref-type="bibr">26</xref>,<xref rid="b27-cise-2024-00906" ref-type="bibr">27</xref>]. The contradictory findings in TSA may stem from yet-undetermined biomechanical mechanisms. For instance, one study linked early stiffness to improved tendon healing after arthroscopic rotator cuff repair [<xref rid="b28-cise-2024-00906" ref-type="bibr">28</xref>]. While rotator cuff pathology was excluded from our study, a similar mechanism may underlie our results. Further research is needed to determine whether such biomechanical factors apply to shoulder arthroplasty for OA.</p><p>After matching to account for comorbidity and demographic differences, patients experienced a periprosthetic fracture rate of 0.85% following treatment with RSA compared to 0.61% in patients treated with TSA. Published literature has demonstrated similarly increased rates of periprosthetic fractures in patients undergoing RSA compared to TSA [<xref rid="b16-cise-2024-00906" ref-type="bibr">16</xref>-<xref rid="b18-cise-2024-00906" ref-type="bibr">18</xref>]. In RSA, acromial and scapular spine fractures as well as humeral fractures are observed, with rates documented to be between 4.5% and 3.5% respectively [<xref rid="b29-cise-2024-00906" ref-type="bibr">29</xref>]. Intraoperative glenoid and humeral fractures are reported to increase the risk of subsequent periprosthetic fracture and may be more likely depending on existing patient characteristics such as glenoid arthritis or osteopenia [<xref rid="b17-cise-2024-00906" ref-type="bibr">17</xref>,<xref rid="b18-cise-2024-00906" ref-type="bibr">18</xref>]. Furthermore, screw placement, implant design, and deltoid lengthening are risk factors implicated in periprosthetic fracture following RSA.</p><p>When comparing nonorthopedic complications, we found greater rates of renal complications as well as deep vein thrombosis in patients undergoing RSA, which is consistent with the existing literature [<xref rid="b16-cise-2024-00906" ref-type="bibr">16</xref>,<xref rid="b30-cise-2024-00906" ref-type="bibr">30</xref>]. Prior research established older age (&gt;70 years), higher comorbidity, and history of cardiac or thromboembolic events as risk factors for 90-day cardiac and thromboembolic complications following primary TSA [<xref rid="b31-cise-2024-00906" ref-type="bibr">31</xref>]. Higher rates of UTIs were also observed among the RSA group. Although previous reports comparing UTI in the setting of RSA versus TSA are sparse, existing research on total joint arthroplasty has identified increasing age, female sex, steroid use, operative time greater than 130 minutes, and preoperative creatinine as risk factors for UTI [<xref rid="b32-cise-2024-00906" ref-type="bibr">32</xref>].Taken together, the literature regarding the risk for medical complications in total joint arthroplasty overwhelmingly attributes differences to age, comorbidity, and sex. Further research is required to identify risk factors for these medical complications based on additional comorbidities not explored in the present study as well as intraoperative factors, which are not available on TriNetX.</p></sec><sec><title>Risk Factors for Orthopedic Complications</title><p>A secondary aim of this study was to determine risk factors for orthopedic complications following shoulder arthroplasty, with a greater number of significant risk factors identified in the TSA group (<xref rid="t3-cise-2024-00906" ref-type="table">Table 3</xref>). Hypertension was a significant risk factor for orthopedic complications in both the RSA and TSA groups. Prior research found hypertension to be a risk factor for fracture as well as extended hospital stay, which may contribute to postoperative stiffness [<xref rid="b33-cise-2024-00906" ref-type="bibr">33</xref>,<xref rid="b34-cise-2024-00906" ref-type="bibr">34</xref>]. Increasing age was associated with a lower risk of orthopedic complications in both the RSA and TSA groups, suggesting that older patients may experience fewer postoperative complications despite often having greater comorbidity burdens. This protective effect may stem from lower functional demands, reduced mechanical stress on implants, and more conservative rehabilitation protocols in older patients, highlighting the need for further investigation.</p><p>Risk factors that were significant exclusively in the RSA group included a personal history of nicotine dependence. Prior research identified active tobacco use as a risk factor for numerous complications in the 90-day window following TSA including fractures, dislocation, and other forms of instability; the underlying mechanisms are multifaceted and have been attributed to the deleterious effects of nicotine on bone density, peripheral blood flow, and gene expression in healing tendons [<xref rid="b35-cise-2024-00906" ref-type="bibr">35</xref>].</p><p>In TSA, risk factors included male sex, COPD, and obesity. Male sex was associated with a lower risk of orthopedic complications, but other literature attributed this to male TSA patients often being younger and more active, which could influence long-term mechanical failure rates. This lack of consensus regarding sex-specific TSA outcomes warrants further study [<xref rid="b36-cise-2024-00906" ref-type="bibr">36</xref>-<xref rid="b40-cise-2024-00906" ref-type="bibr">40</xref>]. COPD was a significant risk factor, consistent with literature linking it to periprosthetic fracture, implant failure, instability, and stiffness, likely due to chronic inflammation and physical inactivity [<xref rid="b41-cise-2024-00906" ref-type="bibr">41</xref>]. Obesity was the strongest TSA-specific risk factor. Prior studies have demonstrated that obesity contributes to higher joint loading, altered biomechanics, increased intraoperative complexity, and, consequently, greater risk of implant loosening, stiffness, periprosthetic fractures [<xref rid="b42-cise-2024-00906" ref-type="bibr">42</xref>-<xref rid="b45-cise-2024-00906" ref-type="bibr">45</xref>].</p></sec><sec><title>Risk Factors for Infectious Complications</title><p>This study also analyzed risk factors for infectious complications within the 90-day postoperative period following RSA and TSA performed for OA (<xref rid="t4-cise-2024-00906" ref-type="table">Table 4</xref>). Diabetes mellitus was a significant risk factor for infections in both the RSA and TSA groups, consistent with previous literature in which diabetes mellitus is well-documented as a risk factor for postoperative infection due to its detrimental effects on immune response and wound healing [<xref rid="b46-cise-2024-00906" ref-type="bibr">46</xref>].</p><p>In the RSA group, male sex and heart failure were identified as significant risk factors for infectious complications. Heart failure, which is associated with systemic inflammation and poor circulation, also significantly raises the risk of infection following RSA [<xref rid="b47-cise-2024-00906" ref-type="bibr">47</xref>]. The higher risk for infection in male RSA patients is well-documented and likely multifactorial, involving a greater comorbidity burden, weaker immune response compared to females, and perhaps social factors such as lower adherence to postoperative care and higher rates of smoking and alcohol use [<xref rid="b36-cise-2024-00906" ref-type="bibr">36</xref>,<xref rid="b48-cise-2024-00906" ref-type="bibr">48</xref>,<xref rid="b49-cise-2024-00906" ref-type="bibr">49</xref>]. There were no significant risk factors for infection exclusive to the TSA group.</p></sec><sec><title>Limitations</title><p>This study is not without its limitations. First, while TriNetX offers the advantage of analyzing a large sample size, this same feature limits data analysis due to its reliance on medical billing codes (e.g., ICD-10, Current Procedural Terminology) to establish cohorts and compare outcomes. Although the selection of codes was informed by a thorough literature review, the coding process is inherently subjective, and as such any given combination of codes may conceivably fail to capture some members of the target cohort (in this case, readmitted TSA or RSA recipients) due to discrepancies in coding across institutions or even inaccuracies in coding. Similarly, not all adverse events identified in this analysis necessarily represent unintended complications of the procedure itself. For example, pre-existing rotator cuff pathology is frequently managed with RSA, and patients who had such diagnoses prior to surgery may continue to experience symptoms in the short term. As a result, follow-up encounters coded for rotator cuff-related issues may be captured as complications in this dataset, even though they may reflect the natural progression of a pre-existing condition rather than a new postoperative complication. Several differences in baseline comorbidities persisted despite propensity matching, including white ethnicity, nicotine dependence, COPD, and ascites; thus, some differences such as the postoperative occurrence of respiratory complications could be attributed in part to baseline group differences in COPD rather than the procedures alone. Additionally, the present study investigated complications confined to the 90-day postoperative window, which may not be sufficient to fully capture procedure-related adverse events that occur later in the postoperative period. One final limitation of the TriNetX database is the possibility that one or more HCO is unresponsive when querying the database, potentially yielding inconsistent results when attempting to analyze outcomes for the same cohort across different time periods; this limitation was mitigated in this our study by replicating the present results multiple times to ensure any significant findings were consistently demonstrated across numerous queries. Furthermore, the retrospective nature of this study may also hinder the ability to establish causality. Variation in surgical techniques and patient management strategies, which are not accounted for in this study, may influence outcomes and should be considered when interpreting the results.</p><p>Future research should examine similar orthopedic and infectious outcomes over a longer postoperative course, beyond the 90-day postoperative window. Additional research encompassing a broader array of complications in various organ systems and/or indications for revision surgery, would likewise contribute to a more complete understanding of the different outcomes observed following TSA and RSA.</p></sec></sec><sec sec-type="conclusions"><title>CONCLUSIONS</title><p>RSA carries a greater risk for orthopedic complications than TSA in the 90-day postoperative period when considering elderly patients undergoing surgery for OA. Significant risk factors for both orthopedic complications and infection included diabetes, hypertension, depression, liver disease, and cardiac arrhythmia. These differences likely result from differences in patient selection, intraoperative factors, and postoperative rehabilitation protocols between the two procedures. The present findings may inform surgical decision-making when assessing a patient&#8217;s candidacy for an elective RSA or TSA for OA and furthermore may help to improve surgical outcomes by encouraging surgeons and patients to address modifiable comorbidities preoperatively.</p></sec></body><back><fn-group><fn fn-type="participating-researchers"><p>
<bold>Author contributions</bold>
</p><p>Conceptualization: SRV, BAL. Data curation: SRV, BAL, AS. Formal analysis: SRV, JS. Investigation: BAL, AS. Methodology: SRV, AS. Project administration: SRV. Resources: MS, JS. Supervision: MS, JS, JV. Validation: MS, JS. Visualization: BAL, JV. Writing &#8211; original draft: SRV, BAL, AS. Writing &#8211; review &amp; editing: SRV, BAL, AS, MS, JS, JV. All authors read and agreed to the published version of the manuscript.</p></fn><fn fn-type="COI-statement"><p>
<bold>Conflict of interest</bold>
</p><p>None.</p></fn><fn fn-type="financial-disclosure"><p>
<bold>Funding</bold>
</p><p>None.</p></fn><fn fn-type="other"><p>
<bold>Data availability</bold>
</p><p>Contact the corresponding author for data availability.</p></fn><fn fn-type="other"><p>
<bold>Acknowledgments</bold>
</p><p>None.</p></fn></fn-group><sec sec-type="supplementary-material"><title>SUPPLEMENTARY MATERIALS</title><p>Supplementary materials can be found via <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.5397/cise.2024.00906" ext-link-type="uri">https://doi.org/10.5397/cise.2024.00906</ext-link>.</p><supplementary-material id="SD1-cise-2024-00906" position="float" content-type="local-data" orientation="portrait"><label>Supplementary Table 1.</label><caption><p>ICD-10 codes used to identify outcomes and complications</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cise-2024-00906-Supplementary-Table-1.pdf" id="d67e454" position="anchor" orientation="portrait"/></supplementary-material></sec><ref-list><title>REFERENCES</title><ref id="b1-cise-2024-00906"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Westermann</surname><given-names>RW</given-names></name><name name-style="western"><surname>Pugely</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Martin</surname><given-names>CT</given-names></name><name name-style="western"><surname>Gao</surname><given-names>Y</given-names></name><name name-style="western"><surname>Wolf</surname><given-names>BR</given-names></name><name name-style="western"><surname>Hettrich</surname><given-names>CM</given-names></name></person-group><article-title>Reverse shoulder arthroplasty in the United States: a comparison of national volume, patient demographics, complications, and surgical indications</article-title><source>Iowa Orthop J</source><year>2015</year><volume>35</volume><fpage>1</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">26361437</pub-id><pub-id pub-id-type="pmcid">PMC4492145</pub-id></element-citation></ref><ref id="b2-cise-2024-00906"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ansok</surname><given-names>CB</given-names></name><name name-style="western"><surname>Muh</surname><given-names>SJ</given-names></name></person-group><article-title>Optimal management of glenohumeral osteoarthritis</article-title><source>Orthop Res Rev</source><year>2018</year><volume>10</volume><fpage>9</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.2147/orr.s134732</pub-id><pub-id pub-id-type="pmid">30774456</pub-id><pub-id pub-id-type="pmcid">PMC6209346</pub-id></element-citation></ref><ref id="b3-cise-2024-00906"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kobayashi</surname><given-names>T</given-names></name><name name-style="western"><surname>Takagishi</surname><given-names>K</given-names></name><name name-style="western"><surname>Shitara</surname><given-names>H</given-names></name><etal/></person-group><article-title>Prevalence of and risk factors for shoulder osteoarthritis in Japanese middle-aged and elderly populations</article-title><source>J Shoulder Elbow Surg</source><year>2014</year><volume>23</volume><fpage>613</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1016/j.jse.2013.11.031</pub-id><pub-id pub-id-type="pmid">24561177</pub-id></element-citation></ref><ref id="b4-cise-2024-00906"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Burden</surname><given-names>EG</given-names></name><name name-style="western"><surname>Batten</surname><given-names>TJ</given-names></name><name name-style="western"><surname>Smith</surname><given-names>CD</given-names></name><name name-style="western"><surname>Evans</surname><given-names>JP</given-names></name></person-group><article-title>Reverse total shoulder arthroplasty</article-title><source>Bone Joint J</source><year>2021</year><volume>103</volume><fpage>813</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1302/0301-620x.103b.bjj-2020-2101</pub-id><pub-id pub-id-type="pmid">33616421</pub-id></element-citation></ref><ref id="b5-cise-2024-00906"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bufquin</surname><given-names>T</given-names></name><name name-style="western"><surname>Hersan</surname><given-names>A</given-names></name><name name-style="western"><surname>Hubert</surname><given-names>L</given-names></name><name name-style="western"><surname>Massin</surname><given-names>P</given-names></name></person-group><article-title>Reverse shoulder arthroplasty for the treatment of three- and four-part fractures of the proximal humerus in the elderly: a prospective review of 43 cases with a short-term follow-up</article-title><source>J Bone Joint Surg Br</source><year>2007</year><volume>89</volume><fpage>516</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1302/0301-620X.89B4.18435</pub-id><pub-id pub-id-type="pmid">17463122</pub-id></element-citation></ref><ref id="b6-cise-2024-00906"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ling</surname><given-names>K</given-names></name><name name-style="western"><surname>Tsouris</surname><given-names>N</given-names></name><name name-style="western"><surname>Nazemi</surname><given-names>A</given-names></name><name name-style="western"><surname>Komatsu</surname><given-names>DE</given-names></name><name name-style="western"><surname>Wang</surname><given-names>ED</given-names></name></person-group><article-title>Identifying risk factors for 30-day readmission after outpatient total shoulder arthroplasty to aid in patient selection</article-title><source>JSES Int</source><year>2023</year><volume>7</volume><fpage>2425</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.1016/j.jseint.2023.06.015</pub-id><pub-id pub-id-type="pmid">37969527</pub-id><pub-id pub-id-type="pmcid">PMC10638568</pub-id></element-citation></ref><ref id="b7-cise-2024-00906"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Crane</surname><given-names>C</given-names></name><name name-style="western"><surname>Wagner</surname><given-names>C</given-names></name><name name-style="western"><surname>Wong</surname><given-names>S</given-names></name><etal/></person-group><article-title>Glenohumeral osteoarthritis: a biological advantage or a missed diagnosis</article-title><source>J Clin Med</source><year>2024</year><volume>13</volume><fpage>2341</fpage><pub-id pub-id-type="doi">10.3390/jcm13082341</pub-id><pub-id pub-id-type="pmid">38673614</pub-id><pub-id pub-id-type="pmcid">PMC11051042</pub-id></element-citation></ref><ref id="b8-cise-2024-00906"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jo</surname><given-names>YH</given-names></name><name name-style="western"><surname>Kim</surname><given-names>DH</given-names></name><name name-style="western"><surname>Lee</surname><given-names>BG</given-names></name></person-group><article-title>When should reverse total shoulder arthroplasty be considered in glenohumeral joint arthritis</article-title><source>Clin Shoulder Elb</source><year>2021</year><volume>24</volume><fpage>272</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.5397/cise.2021.00633</pub-id><pub-id pub-id-type="pmid">34875733</pub-id><pub-id pub-id-type="pmcid">PMC8651594</pub-id></element-citation></ref><ref id="b9-cise-2024-00906"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Loeser</surname><given-names>RF</given-names></name></person-group><article-title>The role of aging in the development of osteoarthritis</article-title><source>Trans Am Clin Climatol Assoc</source><year>2017</year><volume>128</volume><fpage>44</fpage><lpage>54</lpage><pub-id pub-id-type="pmid">28790486</pub-id><pub-id pub-id-type="pmcid">PMC5525396</pub-id></element-citation></ref><ref id="b10-cise-2024-00906"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gerber</surname><given-names>C</given-names></name><name name-style="western"><surname>Pennington</surname><given-names>SD</given-names></name><name name-style="western"><surname>Nyffeler</surname><given-names>RW</given-names></name></person-group><article-title>Reverse total shoulder arthroplasty</article-title><source>J Am Acad Orthop Surg</source><year>2009</year><volume>17</volume><fpage>284</fpage><lpage>95</lpage><pub-id pub-id-type="doi">10.5435/00124635-200905000-00003</pub-id><pub-id pub-id-type="pmid">19411640</pub-id></element-citation></ref><ref id="b11-cise-2024-00906"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Villacis</surname><given-names>D</given-names></name><name name-style="western"><surname>Sivasundaram</surname><given-names>L</given-names></name><name name-style="western"><surname>Pannell</surname><given-names>WC</given-names></name><name name-style="western"><surname>Heckmann</surname><given-names>N</given-names></name><name name-style="western"><surname>Omid</surname><given-names>R</given-names></name><name name-style="western"><surname>Hatch</surname><given-names>GF</given-names><suffix>3rd</suffix></name></person-group><article-title>Complication rate and implant survival for reverse shoulder arthroplasty versus total shoulder arthroplasty: results during the initial 2 years</article-title><source>J Shoulder Elbow Surg</source><year>2016</year><volume>25</volume><fpage>927</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.1016/j.jse.2015.10.012</pub-id><pub-id pub-id-type="pmid">26796602</pub-id></element-citation></ref><ref id="b12-cise-2024-00906"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Daher</surname><given-names>M</given-names></name><name name-style="western"><surname>Boufadel</surname><given-names>P</given-names></name><name name-style="western"><surname>Fares</surname><given-names>MY</given-names></name><etal/></person-group><article-title>Reverse versus anatomic total shoulder arthroplasty for glenohumeral osteoarthritis with intact cuff: a meta-analysis of clinical outcomes</article-title><source>J Shoulder Elbow Surg</source><year>2025</year><volume>34</volume><fpage>190</fpage><lpage>202</lpage><pub-id pub-id-type="doi">10.1016/j.jse.2024.06.026</pub-id><pub-id pub-id-type="pmid">39142432</pub-id></element-citation></ref><ref id="b13-cise-2024-00906"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Glen</surname><given-names>LZ</given-names></name><name name-style="western"><surname>Cheong</surname><given-names>CK</given-names></name><name name-style="western"><surname>Nistala</surname><given-names>KR</given-names></name><name name-style="western"><surname>Sean</surname><given-names>PK</given-names></name><name name-style="western"><surname>Pei</surname><given-names>LT</given-names></name><name name-style="western"><surname>Ruben</surname><given-names>M</given-names></name></person-group><article-title>Outcomes of reverse total shoulder arthroplasties performed for proximal humeral fractures versus elective etiologies</article-title><source>Indian J Orthop</source><year>2022</year><volume>56</volume><fpage>1066</fpage><lpage>72</lpage><pub-id pub-id-type="doi">10.1007/s43465-022-00625-4</pub-id><pub-id pub-id-type="pmid">35669022</pub-id><pub-id pub-id-type="pmcid">PMC9123117</pub-id></element-citation></ref><ref id="b14-cise-2024-00906"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Topaloglu</surname><given-names>U</given-names></name><name name-style="western"><surname>Palchuk</surname><given-names>MB</given-names></name></person-group><article-title>Using a federated network of real-world data to optimize clinical trials operations</article-title><source>JCO Clin Cancer Inform</source><year>2018</year><volume>2</volume><fpage>1</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1200/cci.17.00067</pub-id><pub-id pub-id-type="pmcid">PMC6816049</pub-id><pub-id pub-id-type="pmid">30652541</pub-id></element-citation></ref><ref id="b15-cise-2024-00906"><label>15</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Stapff</surname><given-names>M</given-names></name></person-group><article-title>Use of electronic health data in clinical development [Internet]</article-title><publisher-name>Executives for Health Innovation</publisher-name><year>2018</year><comment>[cited 2025 Feb 4]. Available from: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.ehidc.org/resources/use-electronic-health-data-clinical-development" ext-link-type="uri">https://www.ehidc.org/resources/use-electronic-health-data-clinical-development</ext-link></comment></element-citation></ref><ref id="b16-cise-2024-00906"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ross</surname><given-names>BJ</given-names></name><name name-style="western"><surname>Wu</surname><given-names>VJ</given-names></name><name name-style="western"><surname>McCluskey</surname><given-names>LC</given-names></name><name name-style="western"><surname>O&#8217;Brien</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Sherman</surname><given-names>WF</given-names></name><name name-style="western"><surname>Savoie</surname><given-names>FH</given-names></name></person-group><article-title>Postoperative complication rates following total shoulder arthroplasty (TSA) vs. reverse shoulder arthroplasty (RSA): a nationwide analysis</article-title><source>Semin Arthroplasty</source><year>2020</year><volume>30</volume><fpage>83</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1053/j.sart.2020.05.006</pub-id></element-citation></ref><ref id="b17-cise-2024-00906"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wickman</surname><given-names>JR</given-names></name><name name-style="western"><surname>Goltz</surname><given-names>DE</given-names></name><name name-style="western"><surname>Levin</surname><given-names>JM</given-names></name><name name-style="western"><surname>Lassiter</surname><given-names>T</given-names></name><name name-style="western"><surname>Anakwenze</surname><given-names>OA</given-names></name><name name-style="western"><surname>Klifto</surname><given-names>CS</given-names></name></person-group><article-title>Early aseptic reoperation after shoulder arthroplasty increases risk of subsequent prosthetic joint infection</article-title><source>JSES Int</source><year>2021</year><volume>5</volume><fpage>1067</fpage><lpage>71</lpage><pub-id pub-id-type="doi">10.1016/j.jseint.2021.06.002</pub-id><pub-id pub-id-type="pmid">34766086</pub-id><pub-id pub-id-type="pmcid">PMC8568807</pub-id></element-citation></ref><ref id="b18-cise-2024-00906"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Barco</surname><given-names>R</given-names></name><name name-style="western"><surname>Savvidou</surname><given-names>OD</given-names></name><name name-style="western"><surname>Sperling</surname><given-names>JW</given-names></name><name name-style="western"><surname>Sanchez-Sotelo</surname><given-names>J</given-names></name><name name-style="western"><surname>Cofield</surname><given-names>RH</given-names></name></person-group><article-title>Complications in reverse shoulder arthroplasty</article-title><source>EFORT Open Rev</source><year>2017</year><volume>1</volume><fpage>72</fpage><lpage>80</lpage><pub-id pub-id-type="doi">10.1302/2058-5241.1.160003</pub-id><pub-id pub-id-type="pmid">28461931</pub-id><pub-id pub-id-type="pmcid">PMC5367530</pub-id></element-citation></ref><ref id="b19-cise-2024-00906"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhou</surname><given-names>HS</given-names></name><name name-style="western"><surname>Chung</surname><given-names>JS</given-names></name><name name-style="western"><surname>Yi</surname><given-names>PH</given-names></name><name name-style="western"><surname>Li</surname><given-names>X</given-names></name><name name-style="western"><surname>Price</surname><given-names>MD</given-names></name></person-group><article-title>Management of complications after reverse shoulder arthroplasty</article-title><source>Curr Rev Musculoskelet Med</source><year>2015</year><volume>8</volume><fpage>92</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1007/s12178-014-9252-9</pub-id><pub-id pub-id-type="pmid">25576072</pub-id><pub-id pub-id-type="pmcid">PMC4596185</pub-id></element-citation></ref><ref id="b20-cise-2024-00906"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Christensen</surname><given-names>GV</given-names></name><name name-style="western"><surname>Bozoghlian</surname><given-names>MF</given-names></name><name name-style="western"><surname>Hlas</surname><given-names>AC</given-names></name><name name-style="western"><surname>Rund</surname><given-names>JM</given-names></name><name name-style="western"><surname>Galvin</surname><given-names>JW</given-names></name><name name-style="western"><surname>Patterson</surname><given-names>BM</given-names></name></person-group><article-title>Predictive factors of intraoperative conversion to reverse total shoulder arthroplasty in patients with primary glenohumeral arthritis</article-title><source>JSES Int</source><year>2024</year><month>Oct</month><day>16</day><comment>[Epub]. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1016/j.jseint.2024.09.026" ext-link-type="uri">https://doi.org/10.1016/j.jseint.2024.09.026</ext-link></comment><pub-id pub-id-type="doi">10.1016/j.jseint.2024.09.026</pub-id><pub-id pub-id-type="pmcid">PMC11962541</pub-id><pub-id pub-id-type="pmid">40182276</pub-id></element-citation></ref><ref id="b21-cise-2024-00906"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chalmers</surname><given-names>BP</given-names></name><name name-style="western"><surname>Wagner</surname><given-names>ER</given-names></name><name name-style="western"><surname>Sperling</surname><given-names>JW</given-names></name><name name-style="western"><surname>Cofield</surname><given-names>RH</given-names></name><name name-style="western"><surname>Sanchez-Sotelo</surname><given-names>J</given-names></name></person-group><article-title>Treatment and outcomes of reverse shoulder arthroplasty dislocations</article-title><source>J Shoulder Elb Arthroplast</source><year>2017</year><volume>1</volume><fpage>2471549217695260</fpage><pub-id pub-id-type="doi">10.1177/2471549217695260</pub-id></element-citation></ref><ref id="b22-cise-2024-00906"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kohan</surname><given-names>EM</given-names></name><name name-style="western"><surname>Chalmers</surname><given-names>PN</given-names></name><name name-style="western"><surname>Salazar</surname><given-names>D</given-names></name><name name-style="western"><surname>Keener</surname><given-names>JD</given-names></name><name name-style="western"><surname>Yamaguchi</surname><given-names>K</given-names></name><name name-style="western"><surname>Chamberlain</surname><given-names>AM</given-names></name></person-group><article-title>Dislocation following reverse total shoulder arthroplasty</article-title><source>J Shoulder Elb Surg</source><year>2017</year><volume>26</volume><fpage>1238</fpage><lpage>45</lpage><pub-id pub-id-type="doi">10.1016/j.jse.2016.12.073</pub-id><pub-id pub-id-type="pmid">28162886</pub-id></element-citation></ref><ref id="b23-cise-2024-00906"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mehta</surname><given-names>N</given-names></name><name name-style="western"><surname>Acuna</surname><given-names>AJ</given-names></name><name name-style="western"><surname>McCormick</surname><given-names>JR</given-names></name><etal/></person-group><article-title>Publicly available anatomic total shoulder arthroplasty rehabilitation protocols show high variability and frequent divergence from the 2020 ASSET recommendations</article-title><source>Int J Sports Phys Ther</source><year>2024</year><volume>19</volume><fpage>856</fpage><lpage>67</lpage><pub-id pub-id-type="doi">10.26603/001c.118926</pub-id><pub-id pub-id-type="pmid">38966826</pub-id><pub-id pub-id-type="pmcid">PMC11221330</pub-id></element-citation></ref><ref id="b24-cise-2024-00906"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hochberger</surname><given-names>F</given-names></name><name name-style="western"><surname>Wild</surname><given-names>MF</given-names></name><name name-style="western"><surname>Heinz</surname><given-names>T</given-names></name><name name-style="western"><surname>Rudert</surname><given-names>M</given-names></name><name name-style="western"><surname>List</surname><given-names>K</given-names></name></person-group><article-title>Comparative study on postoperative immobilization in reverse total shoulder arthroplasty: 4 weeks vs. 6 weeks of immobilization yields similar clinical and functional outcomes</article-title><source>J Clin Med</source><year>2024</year><volume>13</volume><fpage>6363</fpage><pub-id pub-id-type="doi">10.3390/jcm13216363</pub-id><pub-id pub-id-type="pmid">39518502</pub-id><pub-id pub-id-type="pmcid">PMC11546419</pub-id></element-citation></ref><ref id="b25-cise-2024-00906"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ghoraishian</surname><given-names>M</given-names></name><name name-style="western"><surname>Hill</surname><given-names>BW</given-names></name><name name-style="western"><surname>Nicholson</surname><given-names>T</given-names></name><name name-style="western"><surname>Ramsey</surname><given-names>ML</given-names></name><name name-style="western"><surname>Williams</surname><given-names>GR</given-names><suffix>Jr</suffix></name><name name-style="western"><surname>Namdari</surname><given-names>S</given-names></name></person-group><article-title>Postoperative stiffness after reverse total shoulder arthroplasty</article-title><source>Shoulder Elbow</source><year>2022</year><volume>14</volume><fpage>150</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1177/1758573220967312</pub-id><pub-id pub-id-type="pmid">35265180</pub-id><pub-id pub-id-type="pmcid">PMC8899328</pub-id></element-citation></ref><ref id="b26-cise-2024-00906"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kirsch</surname><given-names>JM</given-names></name><name name-style="western"><surname>Puzzitiello</surname><given-names>RN</given-names></name><name name-style="western"><surname>Swanson</surname><given-names>D</given-names></name><etal/></person-group><article-title>Outcomes after anatomic and reverse shoulder arthroplasty for the treatment of glenohumeral osteoarthritis: a propensity score-matched analysis</article-title><source>J Bone Joint Surg Am</source><year>2022</year><volume>104</volume><fpage>1362</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">35867705</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2106/JBJS.21.00982</pub-id></element-citation></ref><ref id="b27-cise-2024-00906"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Su</surname><given-names>F</given-names></name><name name-style="western"><surname>Nuthalapati</surname><given-names>P</given-names></name><name name-style="western"><surname>Feeley</surname><given-names>BT</given-names></name><name name-style="western"><surname>Lansdown</surname><given-names>DA</given-names></name></person-group><article-title>Outcomes of anatomic and reverse total shoulder arthroplasty in patients over the age of 70: a systematic review</article-title><source>JSES Rev Rep Tech</source><year>2023</year><volume>3</volume><fpage>181</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1016/j.xrrt.2023.02.003</pub-id><pub-id pub-id-type="pmid">37588441</pub-id><pub-id pub-id-type="pmcid">PMC10426543</pub-id></element-citation></ref><ref id="b28-cise-2024-00906"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Takahashi</surname><given-names>R</given-names></name><name name-style="western"><surname>Kawakami</surname><given-names>K</given-names></name><name name-style="western"><surname>Harada</surname><given-names>Y</given-names></name><name name-style="western"><surname>Kouzaki</surname><given-names>K</given-names></name><name name-style="western"><surname>Kajita</surname><given-names>Y</given-names></name></person-group><article-title>Early postoperative stiffness after arthroscopic rotator cuff repair correlates with improved tendon healing</article-title><source>Arthroscopy</source><year>2024</year><volume>40</volume><fpage>2186</fpage><lpage>94</lpage><pub-id pub-id-type="doi">10.1016/j.arthro.2024.01.038</pub-id><pub-id pub-id-type="pmid">38325498</pub-id></element-citation></ref><ref id="b29-cise-2024-00906"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brusalis</surname><given-names>CM</given-names></name><name name-style="western"><surname>Taylor</surname><given-names>SA</given-names></name></person-group><article-title>Periprosthetic fractures in reverse total shoulder arthroplasty: current concepts and advances in management</article-title><source>Curr Rev Musculoskelet Med</source><year>2020</year><volume>13</volume><fpage>509</fpage><lpage>19</lpage><pub-id pub-id-type="doi">10.1007/s12178-020-09654-8</pub-id><pub-id pub-id-type="pmid">32506260</pub-id><pub-id pub-id-type="pmcid">PMC7340687</pub-id></element-citation></ref><ref id="b30-cise-2024-00906"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ponce</surname><given-names>BA</given-names></name><name name-style="western"><surname>Oladeji</surname><given-names>LO</given-names></name><name name-style="western"><surname>Rogers</surname><given-names>ME</given-names></name><name name-style="western"><surname>Menendez</surname><given-names>ME</given-names></name></person-group><article-title>Comparative analysis of anatomic and reverse total shoulder arthroplasty: in-hospital outcomes and costs</article-title><source>J Shoulder Elbow Surg</source><year>2015</year><volume>24</volume><fpage>460</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1016/j.jse.2014.08.016</pub-id><pub-id pub-id-type="pmid">25441557</pub-id></element-citation></ref><ref id="b31-cise-2024-00906"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Singh</surname><given-names>JA</given-names></name><name name-style="western"><surname>Sperling</surname><given-names>JW</given-names></name><name name-style="western"><surname>Cofield</surname><given-names>RH</given-names></name></person-group><article-title>Cardiopulmonary complications after primary shoulder arthroplasty: a cohort study</article-title><source>Semin Arthritis Rheum</source><year>2012</year><volume>41</volume><fpage>689</fpage><lpage>97</lpage><pub-id pub-id-type="doi">10.1016/j.semarthrit.2011.09.003</pub-id><pub-id pub-id-type="pmid">22055539</pub-id><pub-id pub-id-type="pmcid">PMC3293941</pub-id></element-citation></ref><ref id="b32-cise-2024-00906"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alvarez</surname><given-names>AP</given-names></name><name name-style="western"><surname>Demzik</surname><given-names>AL</given-names></name><name name-style="western"><surname>Alvi</surname><given-names>HM</given-names></name><name name-style="western"><surname>Hardt</surname><given-names>KD</given-names></name><name name-style="western"><surname>Manning</surname><given-names>DW</given-names></name></person-group><article-title>Risk factors for postoperative urinary tract infections in patients undergoing total joint arthroplasty</article-title><source>Adv Orthop</source><year>2016</year><volume>2016</volume><fpage>7268985</fpage><pub-id pub-id-type="doi">10.1155/2016/7268985</pub-id><pub-id pub-id-type="pmid">28018678</pub-id><pub-id pub-id-type="pmcid">PMC5149596</pub-id></element-citation></ref><ref id="b33-cise-2024-00906"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vestergaard</surname><given-names>P</given-names></name><name name-style="western"><surname>Rejnmark</surname><given-names>L</given-names></name><name name-style="western"><surname>Mosekilde</surname><given-names>L</given-names></name></person-group><article-title>Hypertension is a risk factor for fractures</article-title><source>Calcif Tissue Int</source><year>2009</year><volume>84</volume><fpage>103</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1007/s00223-008-9198-2</pub-id><pub-id pub-id-type="pmid">19067019</pub-id></element-citation></ref><ref id="b34-cise-2024-00906"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gupta</surname><given-names>P</given-names></name><name name-style="western"><surname>Quan</surname><given-names>T</given-names></name><name name-style="western"><surname>Patel</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Gu</surname><given-names>A</given-names></name><name name-style="western"><surname>Campbell</surname><given-names>JC</given-names></name></person-group><article-title>Extended length of stay and postoperative complications in octogenarians with hypertension following revision total knee arthroplasty</article-title><source>J Clin Orthop Trauma</source><year>2022</year><volume>26</volume><fpage>101787</fpage><pub-id pub-id-type="doi">10.1016/j.jcot.2022.101787</pub-id><pub-id pub-id-type="pmid">35145852</pub-id><pub-id pub-id-type="pmcid">PMC8814689</pub-id></element-citation></ref><ref id="b35-cise-2024-00906"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schwartz</surname><given-names>AM</given-names></name><name name-style="western"><surname>Farley</surname><given-names>KX</given-names></name><name name-style="western"><surname>Boden</surname><given-names>SH</given-names></name><etal/></person-group><article-title>The use of tobacco is a modifiable risk factor for poor outcomes and readmissions after shoulder arthroplasty</article-title><source>Bone Joint J</source><year>2020</year><volume>102</volume><fpage>1549</fpage><lpage>54</lpage><pub-id pub-id-type="doi">10.1302/0301-620x.102b11.bjj-2020-0599.r1</pub-id><pub-id pub-id-type="pmid">33135438</pub-id></element-citation></ref><ref id="b36-cise-2024-00906"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ezuma</surname><given-names>CO</given-names></name><name name-style="western"><surname>Kosber</surname><given-names>RL</given-names></name><name name-style="western"><surname>Kovacevic</surname><given-names>D</given-names></name></person-group><article-title>Biological sex impacts perioperative complications after reverse shoulder arthroplasty for proximal humeral fracture</article-title><source>JSES Int</source><year>2021</year><volume>5</volume><fpage>371</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1016/j.jseint.2020.12.005</pub-id><pub-id pub-id-type="pmid">34136842</pub-id><pub-id pub-id-type="pmcid">PMC8178601</pub-id></element-citation></ref><ref id="b37-cise-2024-00906"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gruskay</surname><given-names>JA</given-names></name><name name-style="western"><surname>Fu</surname><given-names>M</given-names></name><name name-style="western"><surname>Basques</surname><given-names>BA</given-names></name><etal/></person-group><article-title>Factors affecting length of stay and complications after elective anterior cervical discectomy and fusion: a study of 2164 patients from The American College of Surgeons National Surgical Quality Improvement Project Database (ACS NSQIP)</article-title><source>Clin Spine Surg</source><year>2016</year><volume>29</volume><fpage>E34</fpage><lpage>42</lpage><pub-id pub-id-type="doi">10.1097/BSD.0000000000000080</pub-id><pub-id pub-id-type="pmid">24525748</pub-id></element-citation></ref><ref id="b38-cise-2024-00906"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lehtim&#228;ki</surname><given-names>K</given-names></name><name name-style="western"><surname>Rasmussen</surname><given-names>JV</given-names></name><name name-style="western"><surname>Mokka</surname><given-names>J</given-names></name><etal/></person-group><article-title>Risk and risk factors for revision after primary reverse shoulder arthroplasty for cuff tear arthropathy and osteoarthritis: a Nordic Arthroplasty Register Association study</article-title><source>J Shoulder Elbow Surg</source><year>2018</year><volume>27</volume><fpage>1596</fpage><lpage>601</lpage><pub-id pub-id-type="doi">10.1016/j.jse.2018.02.060</pub-id><pub-id pub-id-type="pmid">29779980</pub-id></element-citation></ref><ref id="b39-cise-2024-00906"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Manoharan</surname><given-names>SR</given-names></name><name name-style="western"><surname>Baker</surname><given-names>DK</given-names></name><name name-style="western"><surname>Pasara</surname><given-names>SM</given-names></name><name name-style="western"><surname>Ponce</surname><given-names>B</given-names></name><name name-style="western"><surname>Deinlein</surname><given-names>D</given-names></name><name name-style="western"><surname>Theiss</surname><given-names>SM</given-names></name></person-group><article-title>Thirty-day readmissions following adult spinal deformity surgery: an analysis of the National Surgical Quality Improvement Program (NSQIP) database</article-title><source>Spine J</source><year>2016</year><volume>16</volume><fpage>862</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1016/j.spinee.2016.03.014</pub-id><pub-id pub-id-type="pmid">26975458</pub-id></element-citation></ref><ref id="b40-cise-2024-00906"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hung</surname><given-names>NJ</given-names></name><name name-style="western"><surname>Wong</surname><given-names>SE</given-names></name></person-group><article-title>Gender influences on shoulder arthroplasty</article-title><source>Curr Rev Musculoskelet Med</source><year>2022</year><volume>15</volume><fpage>21</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1007/s12178-021-09737-0</pub-id><pub-id pub-id-type="pmid">34982405</pub-id><pub-id pub-id-type="pmcid">PMC8804121</pub-id></element-citation></ref><ref id="b41-cise-2024-00906"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>R</given-names></name><name name-style="western"><surname>Lee</surname><given-names>D</given-names></name><name name-style="western"><surname>Mamidi</surname><given-names>IS</given-names></name><name name-style="western"><surname>Probasco</surname><given-names>WV</given-names></name><name name-style="western"><surname>Heyer</surname><given-names>JH</given-names></name><name name-style="western"><surname>Pandarinath</surname><given-names>R</given-names></name></person-group><article-title>Patients with chronic obstructive pulmonary disease are at higher risk for pneumonia, septic shock, and blood transfusions after total shoulder arthroplasty</article-title><source>Clin Orthop Relat Res</source><year>2019</year><volume>477</volume><fpage>416</fpage><lpage>23</lpage><pub-id pub-id-type="doi">10.1097/corr.0000000000000531</pub-id><pub-id pub-id-type="pmid">30664604</pub-id><pub-id pub-id-type="pmcid">PMC6370087</pub-id></element-citation></ref><ref id="b42-cise-2024-00906"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Werner</surname><given-names>BC</given-names></name><name name-style="western"><surname>Burrus</surname><given-names>MT</given-names></name><name name-style="western"><surname>Browne</surname><given-names>JA</given-names></name><name name-style="western"><surname>Brockmeier</surname><given-names>SF</given-names></name></person-group><article-title>Superobesity (body mass index &gt;50 kg/m2) and complications after total shoulder arthroplasty: an incremental effect of increasing body mass index</article-title><source>J Shoulder Elbow Surg</source><year>2015</year><volume>24</volume><fpage>1868</fpage><lpage>75</lpage><pub-id pub-id-type="doi">10.1016/j.jse.2015.05.046</pub-id><pub-id pub-id-type="pmid">26190668</pub-id></element-citation></ref><ref id="b43-cise-2024-00906"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shengyuan</surname><given-names>T</given-names></name><name name-style="western"><surname>Zihang</surname><given-names>X</given-names></name><name name-style="western"><surname>Changbing</surname><given-names>W</given-names></name><name name-style="western"><surname>Junhua</surname><given-names>W</given-names></name><name name-style="western"><surname>Hong</surname><given-names>W</given-names></name></person-group><article-title>The influence of obesity on the complications and outcomes of shoulder arthroplasty: a systematic review and meta-analysis</article-title><source>Acta Orthop Traumatol Turc</source><year>2023</year><volume>57</volume><fpage>154</fpage><lpage>60</lpage><pub-id pub-id-type="doi">10.5152/j.aott.2023.20300</pub-id><pub-id pub-id-type="pmid">37670449</pub-id><pub-id pub-id-type="pmcid">PMC10544269</pub-id></element-citation></ref><ref id="b44-cise-2024-00906"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wall</surname><given-names>KC</given-names></name><name name-style="western"><surname>Politzer</surname><given-names>CS</given-names></name><name name-style="western"><surname>Chahla</surname><given-names>J</given-names></name><name name-style="western"><surname>Garrigues</surname><given-names>GE</given-names></name></person-group><article-title>Obesity is associated with an increased prevalence of glenohumeral osteoarthritis and arthroplasty: a cohort study</article-title><source>Orthop Clin North Am</source><year>2020</year><volume>51</volume><fpage>259</fpage><lpage>64</lpage><pub-id pub-id-type="doi">10.1016/j.ocl.2019.12.001</pub-id><pub-id pub-id-type="pmid">32138863</pub-id></element-citation></ref><ref id="b45-cise-2024-00906"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Linberg</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Sperling</surname><given-names>JW</given-names></name><name name-style="western"><surname>Schleck</surname><given-names>CD</given-names></name><name name-style="western"><surname>Cofield</surname><given-names>RH</given-names></name></person-group><article-title>Shoulder arthroplasty in morbidly obese patients</article-title><source>J Shoulder Elbow Surg</source><year>2009</year><volume>18</volume><fpage>903</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1016/j.jse.2009.02.006</pub-id><pub-id pub-id-type="pmid">19464930</pub-id></element-citation></ref><ref id="b46-cise-2024-00906"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cancienne</surname><given-names>JM</given-names></name><name name-style="western"><surname>Brockmeier</surname><given-names>SF</given-names></name><name name-style="western"><surname>Werner</surname><given-names>BC</given-names></name></person-group><article-title>Association of perioperative glycemic control with deep postoperative infection after shoulder arthroplasty in patients with diabetes</article-title><source>J Am Acad Orthop Surg</source><year>2018</year><volume>26</volume><fpage>e238</fpage><lpage>45</lpage><pub-id pub-id-type="doi">10.5435/jaaos-d-16-00784</pub-id><pub-id pub-id-type="pmid">29688958</pub-id></element-citation></ref><ref id="b47-cise-2024-00906"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hasper</surname><given-names>D</given-names></name><name name-style="western"><surname>Hummel</surname><given-names>M</given-names></name><name name-style="western"><surname>Kleber</surname><given-names>FX</given-names></name><name name-style="western"><surname>Reindl</surname><given-names>I</given-names></name><name name-style="western"><surname>Volk</surname><given-names>HD</given-names></name></person-group><article-title>Systemic inflammation in patients with heart failure</article-title><source>Eur Heart J</source><year>1998</year><volume>19</volume><fpage>761</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.1053/euhj.1997.0858</pub-id><pub-id pub-id-type="pmid">9717010</pub-id></element-citation></ref><ref id="b48-cise-2024-00906"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nolen-Hoeksema</surname><given-names>S</given-names></name></person-group><article-title>Gender differences in risk factors and consequences for alcohol use and problems</article-title><source>Clin Psychol Rev</source><year>2004</year><volume>24</volume><fpage>981</fpage><lpage>1010</lpage><pub-id pub-id-type="doi">10.1016/j.cpr.2004.08.003</pub-id><pub-id pub-id-type="pmid">15533281</pub-id></element-citation></ref><ref id="b49-cise-2024-00906"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fernandez</surname><given-names>AC</given-names></name><name name-style="western"><surname>Bohnert</surname><given-names>KM</given-names></name><name name-style="western"><surname>Bicket</surname><given-names>MC</given-names></name><name name-style="western"><surname>Weng</surname><given-names>W</given-names></name><name name-style="western"><surname>Singh</surname><given-names>K</given-names></name><name name-style="western"><surname>Englesbe</surname><given-names>M</given-names></name></person-group><article-title>Adverse surgical outcomes linked to co-occurring smoking and risky alcohol use among general surgery patients</article-title><source>Ann Surg</source><year>2023</year><volume>278</volume><fpage>201</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1097/sla.0000000000005735</pub-id><pub-id pub-id-type="pmid">36268706</pub-id><pub-id pub-id-type="pmcid">PMC10119331</pub-id></element-citation></ref></ref-list></back><floats-group><fig position="float" id="f1-cise-2024-00906" orientation="portrait"><label>Fig. 1.</label><caption><p>Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) flowchart for patient selection. RSA: reverse shoulder arthroplasty, TSA: total shoulder arthroplasty.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="cise-2024-00906f1.jpg"/></fig><table-wrap position="float" id="t1-cise-2024-00906" orientation="portrait"><label>Table 1.</label><caption><p>Matched and unmatched demographic and comorbidity characteristics for included patients</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" valign="middle" align="left" colspan="1">Variable</th><th colspan="2" valign="middle" align="center" rowspan="1">Unmatched<hr/></th><th rowspan="2" valign="middle" align="center" colspan="1">P-value</th><th colspan="2" valign="middle" align="center" rowspan="1">Matched<hr/></th><th rowspan="2" valign="middle" align="center" colspan="1">P-value</th></tr><tr><th valign="middle" align="center" rowspan="1" colspan="1">RSA</th><th valign="middle" align="center" rowspan="1" colspan="1">TSA</th><th valign="middle" align="center" rowspan="1" colspan="1">RSA</th><th valign="middle" align="center" rowspan="1" colspan="1">TSA</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Cohort population</td><td valign="top" align="center" rowspan="1" colspan="1">5,058</td><td valign="top" align="center" rowspan="1" colspan="1">6,064</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">4,117</td><td valign="top" align="center" rowspan="1" colspan="1">4,117</td><td valign="top" align="center" rowspan="1" colspan="1">-</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Average age at index (yr)</td><td valign="top" align="center" rowspan="1" colspan="1">73.7&#177;5.3</td><td valign="top" align="center" rowspan="1" colspan="1">71.4&#177;4.7</td><td valign="top" align="center" rowspan="1" colspan="1">&lt;0.001<sup><xref rid="tfn1-cise-2024-00906" ref-type="table-fn">*</xref></sup></td><td valign="top" align="center" rowspan="1" colspan="1">72.7&#177;5.0</td><td valign="top" align="center" rowspan="1" colspan="1">72.6&#177;4.8</td><td valign="top" align="center" rowspan="1" colspan="1">0.291</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Female</td><td valign="top" align="center" rowspan="1" colspan="1">3,039 (60.08)</td><td valign="top" align="center" rowspan="1" colspan="1">2,917 (48.10)</td><td valign="top" align="center" rowspan="1" colspan="1">&lt;0.001<sup><xref rid="tfn1-cise-2024-00906" ref-type="table-fn">*</xref></sup></td><td valign="top" align="center" rowspan="1" colspan="1">2,287 (55.55)</td><td valign="top" align="center" rowspan="1" colspan="1">2,270 (55.14)</td><td valign="top" align="center" rowspan="1" colspan="1">0.706</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Male</td><td valign="top" align="center" rowspan="1" colspan="1">1,921 (37.98)</td><td valign="top" align="center" rowspan="1" colspan="1">3,028 (49.93)</td><td valign="top" align="center" rowspan="1" colspan="1">&lt;0.001</td><td valign="top" align="center" rowspan="1" colspan="1">1,743 (42.34)</td><td valign="top" align="center" rowspan="1" colspan="1">1,743 (42.34)</td><td valign="top" align="center" rowspan="1" colspan="1">0.688</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Unknown sex</td><td valign="top" align="center" rowspan="1" colspan="1">98 (1.94)</td><td valign="top" align="center" rowspan="1" colspan="1">119 (1.96)</td><td valign="top" align="center" rowspan="1" colspan="1">0.935</td><td valign="top" align="center" rowspan="1" colspan="1">87 (2.11)</td><td valign="top" align="center" rowspan="1" colspan="1">86 (2.09)</td><td valign="top" align="center" rowspan="1" colspan="1">0.939</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">White</td><td valign="top" align="center" rowspan="1" colspan="1">4,271 (84.44)</td><td valign="top" align="center" rowspan="1" colspan="1">5,290 (87.24)</td><td valign="top" align="center" rowspan="1" colspan="1">&lt;0.001<sup><xref rid="tfn1-cise-2024-00906" ref-type="table-fn">*</xref></sup></td><td valign="top" align="center" rowspan="1" colspan="1">3,551 (86.25)</td><td valign="top" align="center" rowspan="1" colspan="1">3,556 (86.37)</td><td valign="top" align="center" rowspan="1" colspan="1">0.873</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">African American</td><td valign="top" align="center" rowspan="1" colspan="1">263 (5.20)</td><td valign="top" align="center" rowspan="1" colspan="1">231 (3.81)</td><td valign="top" align="center" rowspan="1" colspan="1">&lt;0.001<sup><xref rid="tfn1-cise-2024-00906" ref-type="table-fn">*</xref></sup></td><td valign="top" align="center" rowspan="1" colspan="1">176 (4.28)</td><td valign="top" align="center" rowspan="1" colspan="1">117 (2.30)</td><td valign="top" align="center" rowspan="1" colspan="1">0.957</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Asian</td><td valign="top" align="center" rowspan="1" colspan="1">47 (0.93)</td><td valign="top" align="center" rowspan="1" colspan="1">90 (1.48)</td><td valign="top" align="center" rowspan="1" colspan="1">0.008<sup><xref rid="tfn1-cise-2024-00906" ref-type="table-fn">*</xref></sup></td><td valign="top" align="center" rowspan="1" colspan="1">46 (1.12)</td><td valign="top" align="center" rowspan="1" colspan="1">35 (0.85)</td><td valign="top" align="center" rowspan="1" colspan="1">0.219</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">American Indian</td><td valign="top" align="center" rowspan="1" colspan="1">13 (0.26)</td><td valign="top" align="center" rowspan="1" colspan="1">10 (0.17)</td><td valign="top" align="center" rowspan="1" colspan="1">0.287</td><td valign="top" align="center" rowspan="1" colspan="1">10 (0.24)</td><td valign="top" align="center" rowspan="1" colspan="1">10 (0.24)</td><td valign="top" align="center" rowspan="1" colspan="1">1.000</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Pacific islander</td><td valign="top" align="center" rowspan="1" colspan="1">10 (0.20)</td><td valign="top" align="center" rowspan="1" colspan="1">14 (0.23)</td><td valign="top" align="center" rowspan="1" colspan="1">0.707</td><td valign="top" align="center" rowspan="1" colspan="1">10 (0.24)</td><td valign="top" align="center" rowspan="1" colspan="1">10 (0.24)</td><td valign="top" align="center" rowspan="1" colspan="1">1.000</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Other race</td><td valign="top" align="center" rowspan="1" colspan="1">113 (2.23)</td><td valign="top" align="center" rowspan="1" colspan="1">154 (1.90)</td><td valign="top" align="center" rowspan="1" colspan="1">0.370</td><td valign="top" align="center" rowspan="1" colspan="1">89 (2.16)</td><td valign="top" align="center" rowspan="1" colspan="1">88 (2.14)</td><td valign="top" align="center" rowspan="1" colspan="1">0.939</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Unknown race</td><td valign="top" align="center" rowspan="1" colspan="1">348 (6.88)</td><td valign="top" align="center" rowspan="1" colspan="1">119 (1.96)</td><td valign="top" align="center" rowspan="1" colspan="1">&lt;0.001<sup><xref rid="tfn1-cise-2024-00906" ref-type="table-fn">*</xref></sup></td><td valign="top" align="center" rowspan="1" colspan="1">247 (6.00)</td><td valign="top" align="center" rowspan="1" colspan="1">253 (6.15)</td><td valign="top" align="center" rowspan="1" colspan="1">0.782</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Hispanic or Latino</td><td valign="top" align="center" rowspan="1" colspan="1">134 (2.65)</td><td valign="top" align="center" rowspan="1" colspan="1">89 (1.47)</td><td valign="top" align="center" rowspan="1" colspan="1">&lt;0.001<sup><xref rid="tfn1-cise-2024-00906" ref-type="table-fn">*</xref></sup></td><td valign="top" align="center" rowspan="1" colspan="1">85 (2.06)</td><td valign="top" align="center" rowspan="1" colspan="1">81 (1.97)</td><td valign="top" align="center" rowspan="1" colspan="1">0.754</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Not Hispanic or Latino</td><td valign="top" align="center" rowspan="1" colspan="1">3,928 (77.66)</td><td valign="top" align="center" rowspan="1" colspan="1">4,063 (67.00)</td><td valign="top" align="center" rowspan="1" colspan="1">&lt;0.001<sup><xref rid="tfn1-cise-2024-00906" ref-type="table-fn">*</xref></sup></td><td valign="top" align="center" rowspan="1" colspan="1">3,121 (75.81)</td><td valign="top" align="center" rowspan="1" colspan="1">3,172 (86.37)</td><td valign="top" align="center" rowspan="1" colspan="1">0.186</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Unknown ethnicity</td><td valign="top" align="center" rowspan="1" colspan="1">996 (19.69)</td><td valign="top" align="center" rowspan="1" colspan="1">1,912 (31.53)</td><td valign="top" align="center" rowspan="1" colspan="1">&lt;0.001<sup><xref rid="tfn1-cise-2024-00906" ref-type="table-fn">*</xref></sup></td><td valign="top" align="center" rowspan="1" colspan="1">911 (22.13)</td><td valign="top" align="center" rowspan="1" colspan="1">864 (20.97)</td><td valign="top" align="center" rowspan="1" colspan="1">0.208</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Average BMI (kg/m<sup>2</sup>)</td><td valign="top" align="center" rowspan="1" colspan="1">30.62&#177;6.59</td><td valign="top" align="center" rowspan="1" colspan="1">30.25&#177;6.02</td><td valign="top" align="center" rowspan="1" colspan="1">0.009<sup><xref rid="tfn1-cise-2024-00906" ref-type="table-fn">*</xref></sup></td><td valign="top" align="center" rowspan="1" colspan="1">30.7&#177;6.6</td><td valign="top" align="center" rowspan="1" colspan="1">30.2&#177;6.11</td><td valign="top" align="center" rowspan="1" colspan="1">&lt;0.001<sup><xref rid="tfn1-cise-2024-00906" ref-type="table-fn">*</xref></sup></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Hypertension</td><td valign="top" align="center" rowspan="1" colspan="1">2,741 (54.19)</td><td valign="top" align="center" rowspan="1" colspan="1">2,832 (46.70)</td><td valign="top" align="center" rowspan="1" colspan="1">&lt;0.001<sup><xref rid="tfn1-cise-2024-00906" ref-type="table-fn">*</xref></sup></td><td valign="top" align="center" rowspan="1" colspan="1">2,105 (51.13)</td><td valign="top" align="center" rowspan="1" colspan="1">2,128 (51.69)</td><td valign="top" align="center" rowspan="1" colspan="1">0.612</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Diabetes mellitus</td><td valign="top" align="center" rowspan="1" colspan="1">968 (19.14)</td><td valign="top" align="center" rowspan="1" colspan="1">885 (14.59)</td><td valign="top" align="center" rowspan="1" colspan="1">&lt;0.001<sup><xref rid="tfn1-cise-2024-00906" ref-type="table-fn">*</xref></sup></td><td valign="top" align="center" rowspan="1" colspan="1">707 (17.17)</td><td valign="top" align="center" rowspan="1" colspan="1">716 (17.39)</td><td valign="top" align="center" rowspan="1" colspan="1">0.793</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">History of nicotine dependence</td><td valign="top" align="center" rowspan="1" colspan="1">801 (15.84)</td><td valign="top" align="center" rowspan="1" colspan="1">634 (10.46)</td><td valign="top" align="center" rowspan="1" colspan="1">&lt;0.001<sup><xref rid="tfn1-cise-2024-00906" ref-type="table-fn">*</xref></sup></td><td valign="top" align="center" rowspan="1" colspan="1">551 (13.38)</td><td valign="top" align="center" rowspan="1" colspan="1">541 (13.41)</td><td valign="top" align="center" rowspan="1" colspan="1">0.745</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Heart failure</td><td valign="top" align="center" rowspan="1" colspan="1">441 (8.72)</td><td valign="top" align="center" rowspan="1" colspan="1">265 (4.37)</td><td valign="top" align="center" rowspan="1" colspan="1">&lt;0.001<sup><xref rid="tfn1-cise-2024-00906" ref-type="table-fn">*</xref></sup></td><td valign="top" align="center" rowspan="1" colspan="1">244 (5.93)</td><td valign="top" align="center" rowspan="1" colspan="1">241 (5.85)</td><td valign="top" align="center" rowspan="1" colspan="1">0.801</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">COPD</td><td valign="top" align="center" rowspan="1" colspan="1">451 (8.92)</td><td valign="top" align="center" rowspan="1" colspan="1">351 (5.79)</td><td valign="top" align="center" rowspan="1" colspan="1">&lt;0.001<sup><xref rid="tfn1-cise-2024-00906" ref-type="table-fn">*</xref></sup></td><td valign="top" align="center" rowspan="1" colspan="1">306 (7.43)</td><td valign="top" align="center" rowspan="1" colspan="1">300 (7.29)</td><td valign="top" align="center" rowspan="1" colspan="1">0.800</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">ESRD</td><td valign="top" align="center" rowspan="1" colspan="1">24 (0.47)</td><td valign="top" align="center" rowspan="1" colspan="1">21 (0.35)</td><td valign="top" align="center" rowspan="1" colspan="1">0.289</td><td valign="top" align="center" rowspan="1" colspan="1">15 (0.36)</td><td valign="top" align="center" rowspan="1" colspan="1">17 (0.41)</td><td valign="top" align="center" rowspan="1" colspan="1">0.723</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Ascites</td><td valign="top" align="center" rowspan="1" colspan="1">37 (0.73)</td><td valign="top" align="center" rowspan="1" colspan="1">33 (0.36)</td><td valign="top" align="center" rowspan="1" colspan="1">0.008<sup><xref rid="tfn1-cise-2024-00906" ref-type="table-fn">*</xref></sup></td><td valign="top" align="center" rowspan="1" colspan="1">18 (0.44)</td><td valign="top" align="center" rowspan="1" colspan="1">20 (0.47)</td><td valign="top" align="center" rowspan="1" colspan="1">0.745</td></tr></tbody></table><table-wrap-foot><fn><p>Values are presented as mean&#177;standard deviation or number (%).</p><p>RSA: reverse shoulder arthroplasty, TSA: total shoulder arthroplasty, BMI: body mass index, COPD: chronic obstructive pulmonary disease, ESRD: end-stage renal disease.</p></fn><fn id="tfn1-cise-2024-00906"><label>*</label><p>P-values &lt;0.05.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="t2-cise-2024-00906" orientation="portrait"><label>Table 2.</label><caption><p>Matched incidence of postoperative complications for patients age &#8805;65 after RSA or TSA for osteoarthritis</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="middle" align="left" rowspan="1" colspan="1">Variable</th><th valign="middle" align="center" rowspan="1" colspan="1">RSA</th><th valign="middle" align="center" rowspan="1" colspan="1">TSA</th><th valign="middle" align="center" rowspan="1" colspan="1">Risk difference (%)</th><th valign="middle" align="center" rowspan="1" colspan="1">P-value</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">All-cause mortality</td><td valign="top" align="center" rowspan="1" colspan="1">11 (0.27)</td><td valign="top" align="center" rowspan="1" colspan="1">&#8804;10<sup><xref rid="tfn3-cise-2024-00906" ref-type="table-fn">&#8224;</xref></sup> (0.24)</td><td valign="top" align="center" rowspan="1" colspan="1">0.024</td><td valign="top" align="center" rowspan="1" colspan="1">0.827</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Wound disruptions</td><td valign="top" align="center" rowspan="1" colspan="1">16 (0.39)</td><td valign="top" align="center" rowspan="1" colspan="1">&#8804;10<sup><xref rid="tfn3-cise-2024-00906" ref-type="table-fn">a)</xref></sup> (0.24)</td><td valign="top" align="center" rowspan="1" colspan="1">0.15</td><td valign="top" align="center" rowspan="1" colspan="1">0.239</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#8195;Organ space SSI</td><td valign="top" align="center" rowspan="1" colspan="1">&#8804;10<sup><xref rid="tfn3-cise-2024-00906" ref-type="table-fn">a)</xref></sup> (0.24)</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1">0.24</td><td valign="top" align="center" rowspan="1" colspan="1">0.001<sup><xref rid="tfn2-cise-2024-00906" ref-type="table-fn">*</xref></sup></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#8195;Superficial incisional SSI</td><td valign="top" align="center" rowspan="1" colspan="1">&#8804;10<sup><xref rid="tfn3-cise-2024-00906" ref-type="table-fn">a)</xref></sup> (0.24)</td><td valign="top" align="center" rowspan="1" colspan="1">&#8804;10<sup><xref rid="tfn3-cise-2024-00906" ref-type="table-fn">a)</xref></sup> (0.24)</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1">1.000</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#8195;Deep incisional SSI</td><td valign="top" align="center" rowspan="1" colspan="1">&#8804;10<sup><xref rid="tfn3-cise-2024-00906" ref-type="table-fn">a)</xref></sup> (0.24)</td><td valign="top" align="center" rowspan="1" colspan="1">&#8804;10<sup><xref rid="tfn3-cise-2024-00906" ref-type="table-fn">a)</xref></sup> (0.24)</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1">1.000</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#8195;Wound dehiscence</td><td valign="top" align="center" rowspan="1" colspan="1">&#8804;10<sup><xref rid="tfn3-cise-2024-00906" ref-type="table-fn">a)</xref></sup> (0.24)</td><td valign="top" align="center" rowspan="1" colspan="1">&#8804;10<sup><xref rid="tfn3-cise-2024-00906" ref-type="table-fn">a)</xref></sup> (0.24)</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1">1.000</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Musculoskeletal infections</td><td valign="top" align="center" rowspan="1" colspan="1">57 (1.39)</td><td valign="top" align="center" rowspan="1" colspan="1">16 (0.39)</td><td valign="top" align="center" rowspan="1" colspan="1">0.10</td><td valign="top" align="center" rowspan="1" colspan="1">&lt;0.001<sup><xref rid="tfn2-cise-2024-00906" ref-type="table-fn">*</xref></sup></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Sepsis and unspecified infections</td><td valign="top" align="center" rowspan="1" colspan="1">29 (0.70)</td><td valign="top" align="center" rowspan="1" colspan="1">25 (0.61)</td><td valign="top" align="center" rowspan="1" colspan="1">0.09</td><td valign="top" align="center" rowspan="1" colspan="1">0.585</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Any orthopedic complication</td><td valign="top" align="center" rowspan="1" colspan="1">315 (7.65)</td><td valign="top" align="center" rowspan="1" colspan="1">273 (6.63)</td><td valign="top" align="center" rowspan="1" colspan="1">1.01</td><td valign="top" align="center" rowspan="1" colspan="1">0.072</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#8195;Dislocation</td><td valign="top" align="center" rowspan="1" colspan="1">36 (0.87)</td><td valign="top" align="center" rowspan="1" colspan="1">11 (0.27)</td><td valign="top" align="center" rowspan="1" colspan="1">0.61</td><td valign="top" align="center" rowspan="1" colspan="1">&lt;0.001<sup><xref rid="tfn2-cise-2024-00906" ref-type="table-fn">*</xref></sup></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#8195;Periprosthetic fracture</td><td valign="top" align="center" rowspan="1" colspan="1">35 (0.85)</td><td valign="top" align="center" rowspan="1" colspan="1">&#8804;10<sup><xref rid="tfn3-cise-2024-00906" ref-type="table-fn">a)</xref></sup> (0.24)</td><td valign="top" align="center" rowspan="1" colspan="1">0.61</td><td valign="top" align="center" rowspan="1" colspan="1">&lt;0.001<sup><xref rid="tfn2-cise-2024-00906" ref-type="table-fn">*</xref></sup></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#8195;Scapula fracture</td><td valign="top" align="center" rowspan="1" colspan="1">12 (0.29)</td><td valign="top" align="center" rowspan="1" colspan="1">&#8804;10<sup><xref rid="tfn3-cise-2024-00906" ref-type="table-fn">a)</xref></sup> (0.24)</td><td valign="top" align="center" rowspan="1" colspan="1">0.05</td><td valign="top" align="center" rowspan="1" colspan="1">0.669</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#8195;Implant loosening/failure</td><td valign="top" align="center" rowspan="1" colspan="1">20 (0.49)</td><td valign="top" align="center" rowspan="1" colspan="1">&#8804;10<sup><xref rid="tfn3-cise-2024-00906" ref-type="table-fn">a)</xref></sup> (0.24)</td><td valign="top" align="center" rowspan="1" colspan="1">0.24</td><td valign="top" align="center" rowspan="1" colspan="1">0.067</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#8195;Stiffness</td><td valign="top" align="center" rowspan="1" colspan="1">174 (4.23)</td><td valign="top" align="center" rowspan="1" colspan="1">227 (5.51)</td><td valign="top" align="center" rowspan="1" colspan="1">&#8211;1.29</td><td valign="top" align="center" rowspan="1" colspan="1">0.006<sup><xref rid="tfn2-cise-2024-00906" ref-type="table-fn">*</xref></sup></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#8195;Rotator cuff injury</td><td valign="top" align="center" rowspan="1" colspan="1">59 (1.43)</td><td valign="top" align="center" rowspan="1" colspan="1">17 (0.41)</td><td valign="top" align="center" rowspan="1" colspan="1">1.02</td><td valign="top" align="center" rowspan="1" colspan="1">&lt;0.001<sup><xref rid="tfn2-cise-2024-00906" ref-type="table-fn">*</xref></sup></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#8195;Hematoma</td><td valign="top" align="center" rowspan="1" colspan="1">12 (0.29)</td><td valign="top" align="center" rowspan="1" colspan="1">&#8804;10<sup><xref rid="tfn3-cise-2024-00906" ref-type="table-fn">a)</xref></sup> (0.05)</td><td valign="top" align="center" rowspan="1" colspan="1">0.12</td><td valign="top" align="center" rowspan="1" colspan="1">0.669</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Renal complications</td><td valign="top" align="center" rowspan="1" colspan="1">173 (4.20)</td><td valign="top" align="center" rowspan="1" colspan="1">117 (2.84)</td><td valign="top" align="center" rowspan="1" colspan="1">1.36</td><td valign="top" align="center" rowspan="1" colspan="1">&lt;0.001<sup><xref rid="tfn2-cise-2024-00906" ref-type="table-fn">*</xref></sup></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Cardiovascular complications</td><td valign="top" align="center" rowspan="1" colspan="1">260 (6.32)</td><td valign="top" align="center" rowspan="1" colspan="1">217 (5.27)</td><td valign="top" align="center" rowspan="1" colspan="1">1.04</td><td valign="top" align="center" rowspan="1" colspan="1">0.043<sup><xref rid="tfn2-cise-2024-00906" ref-type="table-fn">*</xref></sup></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Other vascular complications</td><td valign="top" align="center" rowspan="1" colspan="1">23 (0.56)</td><td valign="top" align="center" rowspan="1" colspan="1">41 (1.00)</td><td valign="top" align="center" rowspan="1" colspan="1">&#8211;0.44</td><td valign="top" align="center" rowspan="1" colspan="1">0.024<sup><xref rid="tfn2-cise-2024-00906" ref-type="table-fn">*</xref></sup></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#8195;DVT</td><td valign="top" align="center" rowspan="1" colspan="1">23 (0.56)</td><td valign="top" align="center" rowspan="1" colspan="1">39 (0.95)</td><td valign="top" align="center" rowspan="1" colspan="1">&#8211;0.39</td><td valign="top" align="center" rowspan="1" colspan="1">0.041<sup><xref rid="tfn2-cise-2024-00906" ref-type="table-fn">*</xref></sup></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Respiratory complications</td><td valign="top" align="center" rowspan="1" colspan="1">102 (2.48)</td><td valign="top" align="center" rowspan="1" colspan="1">79 (1.92)</td><td valign="top" align="center" rowspan="1" colspan="1">0.56</td><td valign="top" align="center" rowspan="1" colspan="1">0.084</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#8195;PE</td><td valign="top" align="center" rowspan="1" colspan="1">23 (0.56)</td><td valign="top" align="center" rowspan="1" colspan="1">28 (0.68)</td><td valign="top" align="center" rowspan="1" colspan="1">&#8211;0.12</td><td valign="top" align="center" rowspan="1" colspan="1">0.483</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">UTI</td><td valign="top" align="center" rowspan="1" colspan="1">76 (1.84)</td><td valign="top" align="center" rowspan="1" colspan="1">53 (1.29)</td><td valign="top" align="center" rowspan="1" colspan="1">0.56</td><td valign="top" align="center" rowspan="1" colspan="1">0.041<sup><xref rid="tfn2-cise-2024-00906" ref-type="table-fn">*</xref></sup></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">GI complications</td><td valign="top" align="center" rowspan="1" colspan="1">121 (2.94)</td><td valign="top" align="center" rowspan="1" colspan="1">119 (2.89)</td><td valign="top" align="center" rowspan="1" colspan="1">0.05</td><td valign="top" align="center" rowspan="1" colspan="1">0.896</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Hematological complications</td><td valign="top" align="center" rowspan="1" colspan="1">203 (4.93)</td><td valign="top" align="center" rowspan="1" colspan="1">172 (4.18)</td><td valign="top" align="center" rowspan="1" colspan="1">0.75</td><td valign="top" align="center" rowspan="1" colspan="1">0.101</td></tr></tbody></table><table-wrap-foot><fn><p>Values are presented as number (%).</p><p>RSA: reverse shoulder arthroplasty, TSA: total shoulder arthroplasty, SSI: surgical site infection, DVT: deep vein thrombosis, PE: pulmonary embolism, UTI: urinary tract infections, GI: gastrointestinal.</p></fn><fn id="tfn3-cise-2024-00906"><label>a)</label><p>Less than 10 instances of the complication were found.</p></fn><fn id="tfn2-cise-2024-00906"><label>*</label><p>P-value &lt;0.05; </p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="t3-cise-2024-00906" orientation="portrait"><label>Table 3.</label><caption><p>Multivariate risk factor analysis for orthopedic complications as related to comorbidities of patients undergoing RSA or TSA for osteoarthritis</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" valign="middle" align="left" colspan="1">Covariate</th><th colspan="4" valign="middle" align="center" rowspan="1">RSA<hr/></th><th colspan="4" valign="middle" align="center" rowspan="1">TSA<hr/></th></tr><tr><th valign="middle" align="center" rowspan="1" colspan="1">OR</th><th valign="middle" align="center" rowspan="1" colspan="1">2.5% CI</th><th valign="middle" align="center" rowspan="1" colspan="1">97.5% CI</th><th valign="middle" align="center" rowspan="1" colspan="1">P-value</th><th valign="middle" align="center" rowspan="1" colspan="1">OR</th><th valign="middle" align="center" rowspan="1" colspan="1">2.5% CI</th><th valign="middle" align="center" rowspan="1" colspan="1">97.5% CI</th><th valign="middle" align="center" rowspan="1" colspan="1">P-value</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Age at index</td><td valign="top" align="center" rowspan="1" colspan="1">0.962</td><td valign="top" align="center" rowspan="1" colspan="1">0.942</td><td valign="top" align="center" rowspan="1" colspan="1">0.983</td><td valign="top" align="center" rowspan="1" colspan="1">&lt;0.001<sup><xref rid="tfn4-cise-2024-00906" ref-type="table-fn">*</xref></sup></td><td valign="top" align="center" rowspan="1" colspan="1">0.962</td><td valign="top" align="center" rowspan="1" colspan="1">0.937</td><td valign="top" align="center" rowspan="1" colspan="1">0.988</td><td valign="top" align="center" rowspan="1" colspan="1">0.004<sup><xref rid="tfn4-cise-2024-00906" ref-type="table-fn">*</xref></sup></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Male sex</td><td valign="top" align="center" rowspan="1" colspan="1">0.945</td><td valign="top" align="center" rowspan="1" colspan="1">0.753</td><td valign="top" align="center" rowspan="1" colspan="1">1.187</td><td valign="top" align="center" rowspan="1" colspan="1">0.629</td><td valign="top" align="center" rowspan="1" colspan="1">0.702</td><td valign="top" align="center" rowspan="1" colspan="1">0.550</td><td valign="top" align="center" rowspan="1" colspan="1">0.896</td><td valign="top" align="center" rowspan="1" colspan="1">0.005</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Diabetes mellitus</td><td valign="top" align="center" rowspan="1" colspan="1">1.084</td><td valign="top" align="center" rowspan="1" colspan="1">0.819</td><td valign="top" align="center" rowspan="1" colspan="1">1.434</td><td valign="top" align="center" rowspan="1" colspan="1">0.574</td><td valign="top" align="center" rowspan="1" colspan="1">0.732</td><td valign="top" align="center" rowspan="1" colspan="1">0.517</td><td valign="top" align="center" rowspan="1" colspan="1">1.035</td><td valign="top" align="center" rowspan="1" colspan="1">0.077</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Personal history of nicotine dependence</td><td valign="top" align="center" rowspan="1" colspan="1">1.592</td><td valign="top" align="center" rowspan="1" colspan="1">1.204</td><td valign="top" align="center" rowspan="1" colspan="1">2.106</td><td valign="top" align="center" rowspan="1" colspan="1">0.001<sup><xref rid="tfn4-cise-2024-00906" ref-type="table-fn">*</xref></sup></td><td valign="top" align="center" rowspan="1" colspan="1">1.065</td><td valign="top" align="center" rowspan="1" colspan="1">0.743</td><td valign="top" align="center" rowspan="1" colspan="1">1.527</td><td valign="top" align="center" rowspan="1" colspan="1">0.730</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">COPD</td><td valign="top" align="center" rowspan="1" colspan="1">1.084</td><td valign="top" align="center" rowspan="1" colspan="1">0.819</td><td valign="top" align="center" rowspan="1" colspan="1">1.434</td><td valign="top" align="center" rowspan="1" colspan="1">0.520</td><td valign="top" align="center" rowspan="1" colspan="1">1.650</td><td valign="top" align="center" rowspan="1" colspan="1">1.099</td><td valign="top" align="center" rowspan="1" colspan="1">2.478</td><td valign="top" align="center" rowspan="1" colspan="1">0.016<sup><xref rid="tfn4-cise-2024-00906" ref-type="table-fn">*</xref></sup></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Heart failure</td><td valign="top" align="center" rowspan="1" colspan="1">1.418</td><td valign="top" align="center" rowspan="1" colspan="1">0.995</td><td valign="top" align="center" rowspan="1" colspan="1">2.021</td><td valign="top" align="center" rowspan="1" colspan="1">0.053</td><td valign="top" align="center" rowspan="1" colspan="1">1.140</td><td valign="top" align="center" rowspan="1" colspan="1">0.687</td><td valign="top" align="center" rowspan="1" colspan="1">1.892</td><td valign="top" align="center" rowspan="1" colspan="1">0.611</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Overweight/obesity</td><td valign="top" align="center" rowspan="1" colspan="1">0.942</td><td valign="top" align="center" rowspan="1" colspan="1">0.714</td><td valign="top" align="center" rowspan="1" colspan="1">1.243</td><td valign="top" align="center" rowspan="1" colspan="1">0.672</td><td valign="top" align="center" rowspan="1" colspan="1">1.776</td><td valign="top" align="center" rowspan="1" colspan="1">1.318</td><td valign="top" align="center" rowspan="1" colspan="1">2.393</td><td valign="top" align="center" rowspan="1" colspan="1">&lt;0.001<sup><xref rid="tfn4-cise-2024-00906" ref-type="table-fn">*</xref></sup></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Hypertension</td><td valign="top" align="center" rowspan="1" colspan="1">1.545</td><td valign="top" align="center" rowspan="1" colspan="1">1.196</td><td valign="top" align="center" rowspan="1" colspan="1">1.997</td><td valign="top" align="center" rowspan="1" colspan="1">0.001<sup><xref rid="tfn4-cise-2024-00906" ref-type="table-fn">*</xref></sup></td><td valign="top" align="center" rowspan="1" colspan="1">1.769</td><td valign="top" align="center" rowspan="1" colspan="1">1.348</td><td valign="top" align="center" rowspan="1" colspan="1">2.323</td><td valign="top" align="center" rowspan="1" colspan="1">&lt;0.001<sup><xref rid="tfn4-cise-2024-00906" ref-type="table-fn">*</xref></sup></td></tr></tbody></table><table-wrap-foot><fn><p>RSA: reverse shoulder arthroplasty, TSA: total shoulder arthroplasty, OR: odds ratio, COPD: chronic obstructive pulmonary disease.</p></fn><fn id="tfn4-cise-2024-00906"><label>*</label><p>P-value &lt;0.05.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="t4-cise-2024-00906" orientation="portrait"><label>Table 4.</label><caption><p>Multivariate risk factor analysis for infections as related to comorbidities of patients undergoing RSA or TSA for osteoarthritis</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" valign="middle" align="left" colspan="1">Covariate</th><th colspan="4" valign="middle" align="center" rowspan="1">RSA<hr/></th><th colspan="4" valign="middle" align="center" rowspan="1">TSA<hr/></th></tr><tr><th valign="middle" align="center" rowspan="1" colspan="1">OR</th><th valign="middle" align="center" rowspan="1" colspan="1">2.5% CI</th><th valign="middle" align="center" rowspan="1" colspan="1">97.5% CI</th><th valign="middle" align="center" rowspan="1" colspan="1">P-value</th><th valign="middle" align="center" rowspan="1" colspan="1">OR</th><th valign="middle" align="center" rowspan="1" colspan="1">2.5% CI</th><th valign="middle" align="center" rowspan="1" colspan="1">97.5% CI</th><th valign="middle" align="center" rowspan="1" colspan="1">P-value</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Age at index</td><td valign="top" align="center" rowspan="1" colspan="1">0.939</td><td valign="top" align="center" rowspan="1" colspan="1">0.905</td><td valign="top" align="center" rowspan="1" colspan="1">0.974</td><td valign="top" align="center" rowspan="1" colspan="1">0.001<sup><xref rid="tfn5-cise-2024-00906" ref-type="table-fn">*</xref></sup></td><td valign="top" align="center" rowspan="1" colspan="1">0.939</td><td valign="top" align="center" rowspan="1" colspan="1">0.881</td><td valign="top" align="center" rowspan="1" colspan="1">1.000</td><td valign="top" align="center" rowspan="1" colspan="1">0.051</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Male sex</td><td valign="top" align="center" rowspan="1" colspan="1">1.698</td><td valign="top" align="center" rowspan="1" colspan="1">1.175</td><td valign="top" align="center" rowspan="1" colspan="1">2.452</td><td valign="top" align="center" rowspan="1" colspan="1">0.005</td><td valign="top" align="center" rowspan="1" colspan="1">1.145</td><td valign="top" align="center" rowspan="1" colspan="1">0.661</td><td valign="top" align="center" rowspan="1" colspan="1">1.980</td><td valign="top" align="center" rowspan="1" colspan="1">0.629</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Diabetes mellitus</td><td valign="top" align="center" rowspan="1" colspan="1">1.525</td><td valign="top" align="center" rowspan="1" colspan="1">1.022</td><td valign="top" align="center" rowspan="1" colspan="1">2.277</td><td valign="top" align="center" rowspan="1" colspan="1">0.039<sup><xref rid="tfn5-cise-2024-00906" ref-type="table-fn">*</xref></sup></td><td valign="top" align="center" rowspan="1" colspan="1">2.453</td><td valign="top" align="center" rowspan="1" colspan="1">1.362</td><td valign="top" align="center" rowspan="1" colspan="1">4.416</td><td valign="top" align="center" rowspan="1" colspan="1">0.003<sup><xref rid="tfn5-cise-2024-00906" ref-type="table-fn">*</xref></sup></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Personal history of nicotine dependence</td><td valign="top" align="center" rowspan="1" colspan="1">1.354</td><td valign="top" align="center" rowspan="1" colspan="1">0.902</td><td valign="top" align="center" rowspan="1" colspan="1">2.032</td><td valign="top" align="center" rowspan="1" colspan="1">0.143</td><td valign="top" align="center" rowspan="1" colspan="1">1.419</td><td valign="top" align="center" rowspan="1" colspan="1">0.766</td><td valign="top" align="center" rowspan="1" colspan="1">2.627</td><td valign="top" align="center" rowspan="1" colspan="1">0.266</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">COPD</td><td valign="top" align="center" rowspan="1" colspan="1">1.228</td><td valign="top" align="center" rowspan="1" colspan="1">0.744</td><td valign="top" align="center" rowspan="1" colspan="1">2.027</td><td valign="top" align="center" rowspan="1" colspan="1">0.422</td><td valign="top" align="center" rowspan="1" colspan="1">1.513</td><td valign="top" align="center" rowspan="1" colspan="1">0.655</td><td valign="top" align="center" rowspan="1" colspan="1">3.497</td><td valign="top" align="center" rowspan="1" colspan="1">0.333</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Heart failure</td><td valign="top" align="center" rowspan="1" colspan="1">2.396</td><td valign="top" align="center" rowspan="1" colspan="1">1.504</td><td valign="top" align="center" rowspan="1" colspan="1">3.818</td><td valign="top" align="center" rowspan="1" colspan="1">&lt;0.001<sup><xref rid="tfn5-cise-2024-00906" ref-type="table-fn">*</xref></sup></td><td valign="top" align="center" rowspan="1" colspan="1">0.723</td><td valign="top" align="center" rowspan="1" colspan="1">0.209</td><td valign="top" align="center" rowspan="1" colspan="1">2.497</td><td valign="top" align="center" rowspan="1" colspan="1">0.608</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Overweight/obesity</td><td valign="top" align="center" rowspan="1" colspan="1">1.156</td><td valign="top" align="center" rowspan="1" colspan="1">0.775</td><td valign="top" align="center" rowspan="1" colspan="1">1.725</td><td valign="top" align="center" rowspan="1" colspan="1">0.476</td><td valign="top" align="center" rowspan="1" colspan="1">0.809</td><td valign="top" align="center" rowspan="1" colspan="1">0.426</td><td valign="top" align="center" rowspan="1" colspan="1">0.536</td><td valign="top" align="center" rowspan="1" colspan="1">0.517</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Hypertension</td><td valign="top" align="center" rowspan="1" colspan="1">1.605</td><td valign="top" align="center" rowspan="1" colspan="1">0.988</td><td valign="top" align="center" rowspan="1" colspan="1">2.607</td><td valign="top" align="center" rowspan="1" colspan="1">0.560</td><td valign="top" align="center" rowspan="1" colspan="1">1.924</td><td valign="top" align="center" rowspan="1" colspan="1">0.936</td><td valign="top" align="center" rowspan="1" colspan="1">3.956</td><td valign="top" align="center" rowspan="1" colspan="1">0.075</td></tr></tbody></table><table-wrap-foot><fn><p>RSA: reverse shoulder arthroplasty, TSA: total shoulder arthroplasty, OR: odds ratio, COPD: chronic obstructive pulmonary disease.</p></fn><fn id="tfn5-cise-2024-00906"><label>*</label><p>P-value &lt;0.05.</p></fn></table-wrap-foot></table-wrap></floats-group></article></pmc-articleset>